GL Brands (GRLB) 10-Q 29 Jun 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2018	Jun. 27, 2018
Document And Entity Information
Entity Registrant Name	Freedom Leaf Inc.
Entity Central Index Key	1,581,545
Document Type	10-Q
Document Period End Date	Mar. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		187,048,252
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,018

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2018	Jun. 30, 2017
Current assets
Cash	$ 165,544	$ 2,498
Accounts receivable, net	28,881	0
Inventory, net	82,485	0
Prepaid expense and other current assets	119,615	1,600
Other receivable, net of reserves	1,123	637,817
Total current assets	397,648	641,915
Fix assets, net	196,631	0
Intangible assets, net	316,955	10,820
Goodwill	315,685	0
Other assets	44,185	338,084
Total assets	1,271,104	990,819
Current liabilities
Convertible notes payable, net of discount	0	70,678
Notes payable	759	3,141
Accounts payable	323,924	15,789
Accrued expenses	97,806	31,891
Accrued expenses to related parties	109,500	0
Derivative liabilities	0	52,757
Total current liabilities	531,989	174,256
Non-current liabilities
Other non-current liabilities	0	188,075
Payable to related party	313,713	290,670
Total non-current liabilities	313,713	478,745
Total liabilities	845,702	653,001
Commitments and contingencies		150,000
Stockholders' equity (deficit)
Preferred stock, $0.001 par value, 10,000,000 shares authorized Series A preferred stock, 1,000,000 shares authorized, 948,022 shares issued and outstanding at March 31, 2018 and June 30, 2017, respectively	948	948
Common stock, $0.001 par value, 500,000,000 shares authorized, 161,740,712 and 111,101,795 shares issued, issuable, and outstanding at March 31, 2018 and June 30, 2017, respectively	161,741	111,102
Additional paid-in capital	8,516,596	4,996,756
Accumulated comprehensive income	22	0
Accumulated deficit	(8,247,029)	(4,920,988)
Total Freedom Leaf Inc. stockholders' equity	432,278	187,818
Non-controlling interest	(6,876)	0
Total stockholders' equity	425,402	187,818
Total liabilities and stockholders' equity	$ 1,271,104	$ 990,819

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2018	Jun. 30, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ .001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	948,022	948,022
Preferred stock, shares outstanding	948,022	948,022
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	161,740,712	111,101,795
Common stock, shares outstanding	161,740,712	111,101,795

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Income Statement [Abstract]
Revenue, net	$ 56,254	$ 254,084	$ 63,913	$ 823,204
Operating expenses
Direct costs of revenue	81,045	17,428	150,871	88,792
General and administrative	337,409	247,578	1,186,222	1,170,036
Depreciation and amortization expense	84,935	0	108,251	370
Bad debt expense	221,294	0	637,817	1,500
Marketing and selling	54,237	12,600	58,554	32,319
Total operating expenses	778,920	277,606	2,141,715	1,293,017
Operating loss	(722,666)	(23,522)	(2,077,802)	(469,813)
Other income (expense)
Interest expense	(1,659)	(6,026)	(14,439)	(11,276)
Loss on settlement of debt	(113,936)	0	(419,098)	0
Interest income	7	0	10,331	0
Loss on conversion of debt into common stock	(781,523)	0	(781,523)	0
Gain on extinguishment of liabilities	54,157	0	54,157	0
Change in fair value of embedded conversion features	(36,575)	(2,905)	(59,127)	(2,905)
Beneficial conversion feature	34,178	5,253	(45,416)	(55,014)
Total other income (expense)	(845,351)	(3,678)	(1,255,115)	(69,195)
Provision for income taxes	0	0	0	0
Net loss before non-controlling interest	(1,568,017)	(27,200)	(3,332,917)	(539,008)
Loss attributable to non-controlling interest	6,876	0	6,876	0
Net loss attributable to common stockholders	$ (1,561,141)	$ (27,200)	$ (3,326,041)	$ (539,008)
Net loss attributable to common stockholders per share - basic and diluted	$ (0.01)	$ 0	$ (0.02)	$ (0.01)
Weighted average number of common shares outstanding - basic and diluted	158,509,748	102,022,698	137,114,271	98,283,870
Exchange differences arising on translating foreign operations	$ 22	$ 0	$ 22	$ 0
Total comprehensive loss	(1,561,039)	0	(3,326,019)	0
Total comprehensive loss - Non-controlling interest	(6,978)	0	(6,898)	0
Total comprehensive loss - Controlling interest	$ (1,568,017)	$ (27,200)	$ (3,332,917)	$ (539,008)

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net loss	$ (3,332,917)	$ (539,008)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	108,251	370
Beneficial conversion feature	187,902	55,014
Gain on settlement of contingent liabilities	(150,000)	0
Loss on common stock issued for accounts payable	189,114	0
Issuance of common stock for services	571,858	616,942
Loss on conversion of debt	710,447	0
Change in fair value of embedded conversion features	0	2,905
Loss on revaluation of derivative liabilities	59,217	0
Bad debt expense	637,817	(1,500)
Changes in operating assets and liabilities:
Accounts receivable	(21,451)	500
Inventory	(55,285)	2,465
Prepaid expense	(119,138)	0
Other receivable	0	(399,286)
Other assets	(40,600)	(229,791)
Accounts payable and accrued expenses	607,198	165,085
Accounts payable and accrued expenses to related parties	127,499	103,405
Net cash used in operating activities	(520,088)	(222,899)
Cash flows from (used in) investing activities
Cash acquired in acquisition of GME	3,546	0
Intangible asset acquired	(27,938)	(3,897)
Net cash from (used in) investing activities	(24,392)	(3,897)
Cash flows from financing activities:
Proceeds from capital contributed	0	28,148
Proceeds from related party	0	76,940
Proceeds from sale of common stock	646,058	80,000
Repayments on notes payable	(97,382)	0
Proceeds from notes payable	166,842	46,000
Net cash provided by financing activities	715,518	231,088
Effects of exchange rates on cash	(7,992)	0
Net increase in cash	163,046	4,293
Cash at beginning of period	2,498	1,758
Cash at end of period	165,544	6,051
Supplemental disclosure of cash flow information:
Cash paid for interest	0	0
Cash paid for taxes	0	0
Non-cash investing and financing activities:
Conversion of debt into common stock	0	115,065
Issuance of common stock for accounts payable and accrued expenses	662,459	0
Conversion of common stock into licensing agreement	0	25,000
Issuance of common stock for inventory	27,200	0
Financed purchases of property and equipment	148,500	0
Common stock issued in business combination	396,728	0
Exercise of warrants for the issuance of common stock	215	0
Notes assigned between holders	118,602	0
Initial debt discounts	116,625	0
Common stock issued for settlement of debt	1,346,520	0
Common stock issued for rights agreement	22,000	0
Derivative liability	$ 0	$ 23,918

1. Nature of Operations and Sum

1. Nature of Operations and Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Summary of Significant Accounting Policies	NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization Freedom Leaf Inc. (the “Company,” “we,” “us,” “our,” “Freedom Leaf” or “FRLF”) was incorporated in the State of Nevada on February 21, 2013, under the name of Arkadia International, Inc. The Company originally was engaged in the business of the acquisition of in demand equipment, cars and goods with the intent to resale these in the U.S. territory or export to overseas countries. On October 3, 2014, the Company experienced a change in control. Richard C. Cowan (“Cowan”) acquired a majority of the issued and outstanding common stock of the Company in accordance with stock purchase agreements by and between Cowan and Vladimir and Galina Shekhtman (“Sellers”). On the closing date, October 3, 2014, Cowan purchased from the Sellers 6,950,100 shares of the Company’s outstanding restricted common stock for $100,000, representing 93% of the then-outstanding common stock of the Company. On November 6, 2014, the Company merged with Freedom Leaf Inc., a private Nevada corporation. The Company changed its name from Arkadia International, Inc., to Freedom Leaf Inc. As a result of the merger, the private company was dissolved, the sole officer, director and shareholder of the private company, Clifford J. Perry, became an officer and director of the Company, and Mr. Perry received approximately 48.1% of the Company’s common stock post-merger. See Note 2 for related discussion. For financial reporting purposes, the merger was accounted for as a "reverse merger" and recapitalization rather than a business combination, and the private company was deemed to be the accounting acquirer in the transaction, with the Company deemed to be the acquired company for financial reporting purposes. Consequently, the assets and liabilities and the operations that are reflected in the historical consolidated financial statements of the Company prior to the merger are those of the private company, and were recorded at the historical cost basis of the private company, and the consolidated financial statements after completion of the merger include the assets and liabilities of both the predecessor public company and private company, the historical operations of private company, and the operations of both companies from the date of the merger. Cannabis Business Solutions Inc (“Cannabis Business Solutions”), a Nevada corporation, was formed on February 5, 2014, and is a subsidiary of the Company. This subsidiary had nominal activity until it purchased the LaMarihuana.com assets from Valencia Web Technology S.L., B-97183354, effective April 8, 2017 (see Note 2). Leafceuticals Inc (“Leafceuticals”), formerly known as Cannabiz U, Inc., a Nevada corporation, was formed on February 13, 2014, and is a wholly-owned subsidiary of the Company. This subsidiary began active operations in January 2018. Freedom Leaf International Inc. (“Freedom Leaf International”), a Nevada corporation, was formed on November 27, 2015, and is a wholly-owned subsidiary of the Company. This subsidiary has had no activity to date. Freedom Leaf Cares Inc. (“Freedom Leaf Cares”), a Nevada corporation, was formed on October 1, 2014, and is a wholly-owned subsidiary of the Company. Freedom Leaf Cares was dissolved in 2016. Until dissolution, this subsidiary had no activity. Nature of Operations Freedom Leaf Inc. is a Company that is dedicated to health and wellness products derived from legal Hemp. It is comprised of a group of diversified, international, vertically-integrated hemp businesses and cannabis media companies. Freedom Leaf Inc. has been working since 2014 to build a diverse portfolio of related hemp businesses through strategic acquisitions across the industry. FRLF’s portfolio of acquisitions includes our recently acquired hemp CBD product line Irie CBD; our wholly-owned hemp extraction division Leafceuticals, Inc.; our exclusive health and wellness CBD brand “Hempology;” our hemp greenhouse cultivation with recent acquisition of a facility in Valencia, Spain; our hemp-based rolling paper company Plants to Paper; two of the largest Spanish-speaking cannabis web portals in the world LaMarihuana.com Marihuana-Medicinal.com Freedom Leaf Magazine Through our targeted acquisitions and growth plan execution, the Company has built a solid foundation for our vertically-integrated hemp and cannabis media company to enhance both revenue growth and shareholder value. Our cultivation and extraction divisions allow FRLF to grow and source our own hemp CBD, which allows lower production costs for our wholly-owned CBD product lines, and better gross profit, for our CBD product sales. In addition, our domestic and international media companies permit us to direct organic traffic to our eCommerce sites and retail locations. · Freedom Leaf does not handle, grow, sell, or dispense marijuana or related products in the United States. · Freedom Leaf believes that its European activities are in compliance with relevant EU laws. Basis of Presentation The Company prepares its consolidated financial statements in conformity with generally accepted accounting principles in the United States of America. Principles of Consolidation The consolidated financial statements include the accounts of Freedom Leaf and its subsidiaries, Cannabis Business Solutions, Leafceuticals, Freedom Leaf Cares, and Freedom Leaf International. All significant inter-company balances and transactions have been eliminated in consolidation. Fair Value Measurements We follow accounting guidance for financial and non-financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. We currently measure and report at fair value our intangible assets (due to our impairment analysis) and derivative liabilities. The fair value of intangible assets has been determined using the present value of estimated future cash flows method. The fair value of derivative liabilities is measured using the Black-Scholes option pricing method. The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying consolidated financial statements include the amortization period for intangible assets, valuation and impairment valuation of intangible assets, depreciable lives of the web site and property and equipment, valuation of warrants and beneficial conversion feature debt discounts, valuation of derivatives, valuation of share-based payments and the valuation allowance on deferred tax assets. Reclassifications Certain amounts in the prior period consolidated financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses, total assets, or stockholders’ equity as previously reported. Inventory Inventory is recorded at the lower of cost or market and the cost of sales are recorded utilizing the first in first out (“FIFO”) method. Accounting for Derivatives The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date. Revenue Recognition In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This update provides a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts. We have early adopted this update. We do not believe this guidance will impact the recognition of our primary source of revenue. The adoption of this guidance did not have a material impact on our consolidated financial statements. Net Earnings (Loss) Per Share In accordance with ASC 260-10, “Earnings Per Share,” basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Dilutive common stock equivalent shares, which may dilute future earnings per share, consist of warrants to purchase 4,618,167 shares of common stock at March 31, 2018. Equivalent shares are not utilized when the effect is anti-dilutive. Effect of Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (“ASU No. 2014-09”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in GAAP when it becomes effective. The new standard is effective for annual reporting periods beginning after December 15, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has adopted this update. We do not believe this guidance will impact the recognition of our primary source of revenue. The adoption of this guidance did not have a material impact on our consolidated financial statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This update provides a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts. We have adopted this update. We do not believe this guidance will impact the recognition of our primary source of revenue. The adoption of this guidance did not have a material impact on our consolidated financial statements. In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements (Topic 205) Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In February 2016, the Financial Accounting Standards Board (“FASB”) issued an ASU on lease accounting. The ASU requires the lease rights and obligations arising from lease contracts, including existing and new arrangements, to be recognized as assets and liabilities on the balance sheet. The ASU is effective for reporting periods beginning after December 15, 2018 with early adoption permitted. While the Company is still evaluating the ASU, the Company expects the adoption of the ASU to have a material effect on the Company’s financial condition due to the recognition of the lease rights and obligations as assets and liabilities. The Company does not expect the ASU to have a material effect on the Company’s results of operations, and the ASU will have no effect on cash flows. The Company has evaluated all other recent accounting pronouncements and believes that none of them will have a significant effect on the Company’s financial statement.

2. Definitive Agreements

2. Definitive Agreements	9 Months Ended
	Mar. 31, 2018
Business Combinations [Abstract]
Definitive Agreements	NOTE 2 –DEFINITIVE AGREEMENTS On November 6, 2014, Freedom Leaf Inc., a Nevada corporation and the public company (the “Company,” “Public Company,” “we,” “us,” “our”) entered into a merger agreement with a private Nevada corporation, Freedom Leaf Inc. (the “Private Company”). Prior to the reverse merger, Cowan, the officer and director of the Public Company, had acquired the majority of its outstanding common stock. Clifford J. Perry, the Private Company’s sole officer and director pre-merger (“Perry”), was the owner of record of all of the outstanding common shares of the Private Company (the “Private Company Stock”) prior to the merger. Pursuant to the merger, the Private Company was merged into the Public Company, and Perry, the Private Company’s shareholder, received 83,401.2 shares of Public Company common stock for each share of Private Company stock pre-merger, or 83,401,200 total shares of the Company’s common stock. The closing of the merger was conditioned upon certain, limited customary representations and warranties, as well as the satisfaction or waiver of specified conditions to closing. As the parties satisfied all of the closing conditions, we filed Articles of Merger in Nevada consummating the merger, and shareholders of the Private Company pre-merger (Perry) owned approximately 48.1% of our issued and outstanding common stock post-merger. Following the merger, the Company focused on pursuing Private Company’s historical businesses. The foregoing description of the merger agreement and transaction does not purport to be complete and is qualified in its entirety by the merger agreement, a copy of which has been filed as Exhibit 10.1 to our Quarterly Report on Form 10-Q/A for the period ended December 31, 2014, which is incorporated herein by reference. Accounting Treatment of the Merger For financial reporting purposes, the merger represents a “reverse merger” rather than a business combination, and Private Company is deemed to be the accounting acquirer in the transaction. The merger is being accounted for as a reverse-merger and recapitalization. Private Company is the acquirer for financial reporting purposes and the Public Company (Freedom Leaf Inc., f/k/a Arkadia International, Inc.) is the acquired company. Consequently, the assets and liabilities and the operations that will be reflected in the historical financial statements prior to the merger will be those of the Private Company and will be recorded at the historical cost basis of the Private Company, and the financial statements after completion of the merger will include the assets and liabilities of the Public Company and the Private Company, the historical operations of the Private Company and operations of both companies from the closing date of the Merger. Licensing Rights On February 8, 2016, the Company and Freedom Leaf Netherlands, B.V. (“FLNL”), a company located in the Netherlands, executed a Memorandum of Understanding (“MOU”), wherein the Company granted FLNL a right of first refusal to license certain rights from the Company described below in exchange for a payment of $25,000, and the parties agreed to negotiate a definite license agreement for such rights with the terms of the definitive agreement incorporating the material terms set forth in the MOU. Such rights include FLNL’s rights to use various trademarks of the Company, primarily “Freedom Leaf,” and other related rights, for use in the Netherlands by FLNL, including FLNL’s right to publish a Freedom Leaf magazine in the Netherlands, sell Freedom Leaf products and perform other activities related to the business of the Company. FLNL is a shareholder (common stock and warrants to purchase additional common stock) of the Company. On December 15, 2016, the Company and FLNL executed the license agreement. The agreement provided for a licensing fee of $250,000 with a payment schedule as follows: $70,869 which has been paid from the date of the MOU until the date of the agreement; $25,000 payment every two months, commencing on April 10, 2017 with the last payment on April 10, 2018, and a final payment of $4,131 on June 10, 2018. As of March 31, 2018, the Company has written the receivable off to bad debt. The Company also provided FLNL with warrants to purchase up to 1,000,000 shares of common stock. The warrants have an exercise price of $0.05. The warrants can be exercised as follows: · 250,000 warrants between June 2017 and August 2017; 250,000 warrants between September 2017 and November 2017; 250,000 warrants between December 2017 and February 2018; and 250,000 warrants between March 2018 and May 2018. See Notes 7 and 12. On December 15, 2016, the Company and Freedom Leaf Iberia, B.V. (“FLI”), a company incorporated under the laws of the Netherlands, executed a license agreement. The licensing agreement provides FLI the distribution rights to the Company’s magazine and other “Freedom Leaf” branded merchandise. The territory of the agreement is Spain and Portugal. The agreement provided for a license fee of $250,000 payable to the Company. The payment schedule provides for a $25,000 payment every two months, beginning on April 20, 2017, concluding on April 20, 2018, with a final payment of $75,000 on June 20, 2018. As the Company is allowing for progress payments, the balance is shown net of imputed interest on the balance sheet. The Company also provided FLI with warrants to purchase up to 1,000,000 shares of common stock. The warrants have an exercise price of $0.05. The warrants can be exercised as follows: 250,000 warrants between June 2017 and August 2017; 250,000 warrants between September 2017 and November 2017; 250,000 warrants between December 2017 and February 2018; and 250,000 warrants between March 2018 and May 2018. See Notes 8 and 12. As of March 31, 2018, the Company has written the receivable off to bad debt. On March 31, 2017, the Company entered into a license agreement with BBD Healthcare Strategies, LLC, a Florida limited liability company (“BBDHS”), pursuant to which BBDHS received distribution rights to the Company’s magazine and other “Freedom Leaf” branded merchandise for the State of Florida, in consideration of (1) a license fee of $250,000, paid $25,000 at execution, and $25,000 due August 2017, October 2017, December 2017, February 2018, March 2018, April 2018, May 2018 and concluding June 2018, with a final payment of $50,000, (2) ongoing royalties of 5% for sales of Company merchandise purchased from the Company, (3) ongoing royalties of 10% for sales of Company merchandise purchased from a third-party supplier, and (4) ongoing royalties of 33% for Company seminars and conferences. As the Company is allowing for progress payments, the balance is shown net of imputed interest on the balance sheet. The Company also provided BBDHS with warrants to purchase 1,200,000 shares of Company common stock at an exercise price of $0.05, exercisable as follows: 240,000 shares between September 1, 2017 and October 31, 2017, 240,000 shares between November 1, 2017 and December 31, 2017, 240,000 shares between January 1, 2018 and February 28, 2018, 240,000 shares between March 1, 2018 and May 30, 2018, and 240,000 shares between June 1, 2018 and July 30, 2018. See Notes 8 and 12. As of March 31, 2018, the Company has written the receivable off to bad debt. Incubation Agreement On January 18, 2016, the Company and Plants to Paper, LLC (“PTP”), a New Jersey limited liability company, executed an Incubation Agreement. PTP owned the patent pending application 62/245,153 (the “Patent”) with the title being “Rolling Papers and Blunt Wraps made from 100% Marijuana.” PTP agreed to transfer its ownership rights in the patent application to the Company, as well as PTP’s Medical Marijuana / Cannabis/Hemp Industry Incubator program. The Company agreed to supply management services and to fund the early stage development of PTP. The Incubation Agreement is for a period of twelve months. PTP will provide the Company with 20% of the outstanding membership shares of PTP in exchange for its services. The costs of patent registrations in the United States and other countries will be the liability of PTP. As of March 31, 2018, PTP had no activity. On February 1, 2017, the Agreement was modified for the following items: a) to provide 25% of the outstanding membership shares of PTP; b) require that the Patent be assigned to PTP; and c) acknowledge that the ownership rights have not been transferred to the Company as of that date. To-date, ownership rights have not been transferred. Sales Representation Contract On December 22, 2016, the Company and NuAxon BioScience, Inc. (“NuAxon”), a Delaware corporation, executed a Sales Representation Contract. NuAxon is a manufacturer and distributor for bulk extracts, Rebel Herbs brand products, and Intelligence Tree brand products. The contract appoints the Company as NuAxon’s sales representative worldwide. The contract is for a period of one year and shall automatically renew for successive terms of the same duration. The contract provides a commission for sales by the Company at rates as follows: a) bulk extracts is 9% with a 2% bonus on annual sales above $500,000; b) Rebel Herbs and Intelligence Tree brand products is 10% with a 3% bonus on annual sales above $1,000,000. As of March 31, 2018, there have been no sales or commissions earned. Equipment Sales Representative Contract On December 22, 2016, the Company and NuAxon executed an Equipment Sales Representative Contract. NuAxon is a manufacturer and distributor for extraction equipment. The contract appoints the Company as NuAxon’s equipment sales representative worldwide. The contract is for a period of one year and shall automatically renew for successive terms of the same duration. The contract provides a commission for sales by the Company at various rates ranging from 3% to 10%, dependent on the cumulative annual sales. On March 15, 2017, the Company entered into an Exclusive Distribution Agreement with NuAxon to sell NuAxon’s CO2 extraction equipment pursuant to which the Company would be paid increasing commissions depending on gross sales of the equipment. On March 16, 2017, the Company issued a purchase order (the “Purchase Order”) to NuAxon to purchase extraction equipment for one of the Company’s customers. As of March 31, 2018, there were no sales. LaMarihuana Purchase On May 30, 2017, with an effective date of April 8, 2017 as per the Bill of Sale, Cannabis Business Solutions Inc. (the “Buyer”), a wholly-owned Nevada subsidiary of the registrant, Freedom Leaf Inc., entered into an Asset Purchase Agreement with Valencia Web Technology S.L., B-97183354, a Spanish limited liability company (Sociedad de Responsabilidad Limitada) (the “Seller,” or “Valencia”) to purchase the Seller’s assets, including its cash and cash equivalents, equipment, inventory, receivables, and two of its websites www.lamarihuana.com and www.marihuana-medicinal.com (but not including the Seller’s website cannabislandia.com), for a purchase price consisting of a 10% interest in the Buyer, and 3,000,000 shares of common stock of the registrant, valued at $300,000 (the “Initial FRLF Shares”), with additional shares of the registrant’s common stock due six months (October 8, 2017) following closing if, at such time, the average closing price of the registrant’s common stock during the previous five trading days is less than $0.10/share. Such additional shares shall be calculated as follows: $300,000 minus the product of (a) the Initial FRLF Shares multiplied by (b) the average closing price of the registrant’s common stock during the five trading days immediately preceding the True-Up Date (the “True-Up Price”), with such difference divided by the True-Up Price. On October 8, 2017, the Company removed the previously recorded contingent liability and recorded 4,142,857 shares of common stock as issuable, with a value of $126,000. On February 7, 2018, the Company and the Buyer agreed that because of the increase in the value of the Company’s common stock, the Buyer had waived its right to additional shares of common stock as stated herein. Therefore, on February 7, 2018, the Company reversed its recording of the 4,142,857 shares of common stock recorded as issuable. See Note 17. The Company is in the process of meeting international requirements for the complete use of the web sites by the Company. This process is expected to be completed before the end of this fiscal year.

3. Business Combination

3. Business Combination	9 Months Ended
	Mar. 31, 2018
Business Combinations [Abstract]
Business Combination	NOTE 3 –BUSINESS COMBINATION Green Market Europe Purchase On January 5, 2018 as amended on February 5, 2018, with an effective date of January 5, 2018, the Company consummated its previously-announced acquisition of 100% of the capital stock of Green Market Europe, S.L. (“GME”), a Spanish producer of hemp products. GME’s facilities include: a 21,000 square foot light deprivation greenhouse; a 43,000 square foot indoor growing research facility, and over 200 acres of outdoor production space. The light deprivation allows the increase of the number of yearly crops from 3 to 4 crops a year, and the 43,000 square foot indoor grow facility is used for genetic research and cultivating additional hemp crops. GME is strategically located in Elche, Alicante, an important Spanish business hub, with great year-round weather conditions for agricultural growing and a long tradition of growing hemp. From its inception to-date, GME has had negligible operations. Purchase Consideration: In consideration for the acquisition, the Company paid to GME’s seller $320,205 in cash and Company common stock as follows: (i) $24,805 (which amount was paid by a third party, and to whom the Company owes that amount), and (ii) 4,220,000 shares of the Company’s common stock valued on the Company’s Balance Sheet at $295,400. Additionally: (i) additional shares will be issuable if the volume weighted-average price of the Company’s stock between January 5, 2018 and July 3, 2018 is less than $0.10 per share, and (ii) the sellers of GME have the option to repurchase all of the assets of GME for €100 (and the assumption of GME’s liabilities) if the volume weighted-average price of the Company’s stock between January 5, 2018 and January 5, 2019 is less than $0.01 per share. Assets acquired, and liabilities assumed, at fair value: The provisional fair value of the purchase consideration issued to the sellers of GME was allocated to the net tangible assets acquired. We accounted for the acquisition of GME as the purchase of a business under GAAP under the acquisition method of accounting, the assets and liabilities acquired were recorded as of the acquisition date, at their respective fair values and consolidated with those of our company. The fair value of the net assets acquired, net of Liabilities assumed, was approximately $20,285. The excess of the aggregate fair value of the net tangible assets has been treated as Goodwill. The purchase price allocation was based, in part, on management’s knowledge of GME’s business and is preliminary. Once we complete our analysis to finalize the purchase price allocation, which includes finalizing the valuation report from a third-party appraiser and a review of potential intangible assets, it is reasonably possible that, there could be significant changes to the preliminary values below. Consideration given: Common stock shares given $ 295,400 Total consideration given $ 295,400 Fair value of identifiable assets acquired, and liabilities assumed: Cash $ 3,546 Accounts receivable 7,430 Fixed assets, net 64,891 Intangible assets, net 5,176 Accounts payable (71,478 ) Acquisition payable (24,805 ) Payable to shareholders (5,045 ) Total identifiable net liabilities (20,285 ) Goodwill 315,685 Total consideration $ 295,400 During March, April and May of 2018, in connection with the Company’s preliminary audit of GME, the Company’s management discovered several irregularities regarding GME’s operations and its sellers’ activities before and after the consummation of the Company’s acquisition of that business. Based on investigation of these discoveries, the Company, effective June 4, 2018, consummated a termination agreement with GME’s seller. In connection with that agreement, GME’s sellers returned to the Company the 4,220,000 shares it had previously issued to the sellers. The Company will write off the approximately $33,000 it had invested cumulatively in GME in addition to the stock issuance.

4. Going Concern

4. Going Concern	9 Months Ended
	Mar. 31, 2018
Going Concern
Going Concern	NOTE 4– GOING CONCERN The Company has a net loss attributable to common stockholders for the nine months ended March 31, 2018 of $3,326,041 and working capital deficit as of March 31, 2018 of $134,341 and has used cash in operations of $520,088 for the nine months ended March 31, 2018. In addition, as of March 31, 2018, the Company had a stockholders’ equity and accumulated deficit of $425,402 and $8,247,029, respectively. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date of the issuance of these financial statements. The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The ability of the Company to continue its operations is dependent on the execution of management’s plans, which include the raising of capital through the debt and/or equity markets, until such time that funds provided by operations are sufficient to fund working capital requirements. If the Company were not to continue as a going concern, it would likely not be able to realize its assets at values comparable to the carrying value or the fair value estimates reflected in the balances set out in the preparation of the consolidated financial statements. There can be no assurances that the Company will be successful in generating additional cash from the equity/debt markets or other sources to be used for operations. The consolidated financial statements do not include any adjustments relating to the recoverability of assets and classification of assets and liabilities that might be necessary. Based on the Company’s current resources, the Company will not be able to continue to operate without additional immediate funding. Should the Company not be successful in obtaining the necessary financing to fund its operations, the Company would need to curtail certain or all operational activities and/or contemplate the sale of its assets, if necessary.

5. Commitments and Contingencie

5. Commitments and Contingencies	9 Months Ended
	Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 5 – COMMITMENTS AND CONTINGENCIES Legal Matters From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of the date of this report, there were no pending or threatened lawsuits. Lease Commitment We lease approximately 2,800 square feet of office space in Las Vegas, Nevada, pursuant to a lease that will expire on December 31, 2019. This facility serves as our corporate headquarters. After December 31, 2017, the Company has the option to opt out of the lease. Future minimum lease payments under these leases are as follows: 2018 $ 5,982 2019 18,943 Total $ 24,925 Rent expense for the nine months ended March 31, 2018 and 2017 was $23,334 and $28,021, respectively.

6. Related Parties

6. Related Parties	9 Months Ended
	Mar. 31, 2018
Related Party Transactions [Abstract]
Related Parties	NOTE 6 – RELATED PARTIES Cowan, a former director and officer of the Company, has payables and accruals due to him of $313,713 and $269,226 as of March 31, 2018 and June 30, 2017, respectively. The payable, as agreed upon verbally, has a maturity date greater than one year, without any other set terms for repayment. Imputed interest is immaterial. Clifford J. Perry (“Perry”), Chief Executive officer, Chief Financial Officer, and a director of the Company, has payables and accruals due to him of $0 and $21,444 as of March 31, 2018 and June 30, 2017, respectively. Imputed interest is immaterial. On July 31, 2017, the Company issued 5,784,061 shares of common stock to Cliff Perry for accrued compensation of $112,500. See Note 12 Raymond P. Medeiros (“Medeiros”), a director of the Company, has payables and accruals due to him of $0 and $0 as of March 31, 2018 and June 30, 2017, respectively. Imputed interest is immaterial. On July 31, 2017, the Company issued 2,699,228 shares of common stock to Raymond Medeiros for accrued compensation of $52,500. See Note 12. On October 31, 2017, the Company issued 850,000 shares of common stock to Paul F. Pelosi, Jr. (“Pelosi”), in regard to his appointment as Chairman of the Board on November 1, 2017, for compensation for the period November 1, 2017 through January 31, 2018. The Company was obligated to issue on February 1, 2018, an additional 1,250,000 options for common stock with an exercise price of $0.04, with an expiration date eighteen months after the issuance. On February 12, 2018, the Company issued 1,250,000 warrants for common stock to Paul Pelosi in satisfaction of this obligation. The warrants have an exercise price of $0.04 and expire August 11, 2018 (see Note 12). On November 10, 2017, the Company sold 967,000 shares of common stock to Pelosi for $14,500, based on a per share price of $0.01499. On January 18, 2018, the Company appointed Richard Groberg, via his company, RSGroberg Consulting, LLC, as its Chief Financial Officer to serve for an initial, two-year term. In consideration of the services to be performed by Groberg, the Company: (i) issued 800,000 shares of common stock, and (ii) $5,000 per month compensation payable: (1) prior to the date that the Company is paying monthly compensation to its directors primarily in cash, in 600,000 shares of common stock (representing the first 12 months’ compensation), and (2) payable in cash thereafter. See Note 17. The 800,000 and 600,000 shares of common stock were issued on January 18, 2018 and valued at $81,200 and $60,900, respectively. On January 18, 2018, Pelosi purchased 1,050,000 shares of common stock for $21,000.

7. Other Receivables

7. Other Receivables	9 Months Ended
	Mar. 31, 2018
Receivables [Abstract]
Other Receivables	NOTE 7 – OTHER RECEIVABLES The Company has three licensing agreements with the following: FLNL, FLI and BBDHS (see Note 2). The receivable, per entity, as recorded in Other Receivables as of March 31, 2018, is as follows: March 31, June 30, FLNL $ 176,779 $ 173,551 FLI 246,178 240,555 BBDHS 225,186 223,711 Subtotal 648,143 637,817 Less: Allowance ( 648,143 ) – Net Balance $ – $ 637,817 As of March 31, 2018, FLNL, FLI and BBDHS are behind on payments of $100,000, $100,000, and $75,000, respectively. The Company and FLI agreed to a legal right of offset in regards to a balance of $60,000 owed by the Company to FLI. The revenue streams as stated herein have been delayed due to unforeseen circumstances. Thus, the Company granted deferment on the payments with each entity. Both FLNL and FLI expected to begin making payment sometime in 2018. As of the date of this report, the Company has not received payment, therefore, the Company has recorded an allowance of $648,143.

8. Fixed Assets

8. Fixed Assets	9 Months Ended
	Mar. 31, 2018
Property, Plant and Equipment [Abstract]
Fixed Assets	NOTE 8– FIXED ASSETS The Company has fixed assets related to equipment and capital improvements. The depreciation of the equipment and capital improvements is over a five-year and two-year period, respectively. As of March 31, 2018, and June 30, 2017, the Company had fixed assets, net of accumulated depreciation, of $196,631 and $0, respectively. The fixed assets are as follows: March 31, June 30, 2018 2017 Equipment $ 221,200 $ – Total fixed assets 221,200 – Less: Accumulated depreciation (24,569 ) – Fixed assets, net $ 196,631 $ – The depreciation expense for the nine months ended March 31, 2018 and 2017, was $24,569 and $0, respectively.

9. Intangible Assets

9. Intangible Assets	9 Months Ended
	Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	NOTE 9 – INTANGIBLE ASSETS The Company has intangible assets related to website development. The amortization of the intangible assets is over a five-year period. As of March 31, 2018, and June 30, 2017, the Company had intangible assets, net of accumulated amortization, of $316,955 and $10,820, respectively. The intangible assets are as follows: March 31, June 30, 2018 2017 Website development $ 401,980 $ 12,245 Total intangible assets 401,980 12,245 Less: Accumulated amortization (85,025 ) (1,425 ) Intangible assets, net $ 316,955 $ 10,820 The amortization expense for the nine months ended March 31, 2018 and 2017, was $83,722 and $370, respectively. The following table presents the amortization for the next five years: 2018 $ 5,136 2019 15,127 2020 1,044 2021 1,044 2022 and thereafter 2,422 Total $ 24,773

10. Derivatives

10. Derivatives	9 Months Ended
	Mar. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	NOTE 10 – DERIVATIVES Embedded Conversion Option Derivatives Due to the conversion terms of certain promissory notes, the embedded conversion options met the criteria to be bifurcated and presented as derivative liabilities. The Company calculated the estimated fair values of the liabilities for embedded conversion option derivative instruments at the original note inception date and settlement dates and at June 30, 2017, using the Black-Scholes option pricing model using the share prices of the Company’s stock on the dates of valuation and using the following ranges for volatility, expected term and the risk-free interest rate at each respective valuation date, no dividend has been assumed for any of the periods: March 31, 2018 June 30, 2017 Note Inception Date Volatility N/A 141% 170% - 232% Expected Term N/A 0.33 - 0.96 years 0.75 - 1.0 years Risk-Free Interest Rate N/A 0.84% 1.07% - 1.33% The following reflects the initial fair value on the note inception date and changes in fair value through March 31, 2018, which reflects that all promissory notes were converted and/or paid leaving no outstanding promissory notes as of March 31, 2018: Embedded conversion option derivative liability fair value on June 30, 2017 $ 52,757 Note modifications adjustment 43,866 Adjustment for extinguishment of notes and conversion of notes (91,653 ) Change in fair value in fiscal year 2018 (4,970 ) Embedded conversion option derivative liability fair value on March 31, 2018 $ –

11. Convertible Notes Payable,

11. Convertible Notes Payable, Net of Premiums and Notes Payable	9 Months Ended
	Mar. 31, 2018
Debt Disclosure [Abstract]
Convertible Notes Payable, Net of Premiums and Notes Payable	NOTE 11 – CONVERTIBLE NOTES PAYABLE, NET OF PREMIUMS AND NOTES PAYABLE Convertible notes, net of discounts and notes payable March 31, 2018 June 30, 2017 Principal, Principal, Debt net of Debt net of Principal Discounts Discounts Principal Discounts Discounts PureEnergy $ – $ – $ – $ 15,475 $ (7,489 ) $ 7,986 PureEnergy – – – 13,480 (5,565 ) 7,915 PowerUp – – – 75,000 (39,330 ) 35,670 PowerUp – – – 38,000 (18,893 ) 19,107 Total $ – $ – $ – $ 141,955 $ (71,277 ) $ 70,678 On July 7, 2015, the Company executed a convertible promissory note for $5,000 with Bruce Perlowin. The note is for one year, 12% interest rate, and convertible at $0.10 per share. The current price at that date was $0.085, which is less than the conversion price. The stock price for our common stock as of September 30, 2015 was $0.40. Our common stock is thinly traded therefore our price, as management has determined, is not indicative of our valuation. In October 2015, the Company issued common stock for services to unrelated parties and the common stock was values at $0.20, therefore, the $0.20 was used for valuation purposes for this note. A beneficial conversion feature of $5,000 was recorded and subsequently amortized. The Company has recorded accrued interest of $467 as of March 31, 2018. On April 15, 2016, Mr. Perlowin converted the principal of this promissory note into 50,000 shares of common stock. The accrued interest was not converted. On August 12, 2015, the Company executed a convertible promissory note for $5,000 with Bruce Perlowin. The note is for one year, 12% interest rate, and convertible at $0.10 per share. The current price at that date was $0.10, which is less than the conversion price. The stock price for our common stock as of September 30, 2015 was $0.40. Our common stock is thinly traded therefore our price, as management has determined, is not indicative of our valuation. In October 2015, the Company issued common stock for services to unrelated parties and the common stock was values at $0.20, therefore, the $0.20 was used for valuation purposes for this note. A beneficial conversion feature of $5,000 was recorded and subsequently amortized. The Company has recorded accrued interest of $408 as of March 31, 2018. On April 15, 2016, Mr. Perlowin converted the principal of this promissory note into 50,000 shares of common stock. The accrued interest was not converted. On August 20, 2015, the Company executed a convertible promissory note for $12,500 with Svetlana Ogorodnikova. The note matures on February 19, 2016, 12% interest rate, and convertible at $0.10 per share. The current price at that date was $0.085, which is less than the conversion price. The stock price for our common stock as of December 31, 2015 was $0.40. Our common stock is thinly traded therefore our price, as management has determined, is not indicative of our valuation. In October 2015, the Company issued common stock for services to unrelated parties and the common stock was values at $0.20, therefore, the $0.20 was used for valuation purposes for this note. A beneficial conversion feature of $12,500 was recorded and subsequently amortized. The Company has recorded accrued interest of $986 as of March 31, 2018. On February 19, 2016, Ms. Ogorodnikova granted the Company an extension on the due date to June 30, 2016. On April 15, 2016, Ms. Ogorodnikova converted the principal of this promissory note into 125,000 shares of common stock. The accrued interest was not converted. On November 1, 2016, the Company executed a collateralized secured promissory note with Eagle Equities, LLC (“Eagle”) for $25,000. The Company netted $23,000 due to legal fees of $2,000. The note has a conversion discount of 45% based on the lowest closing price of the 20 days prior to conversion. The Company recorded a debt discount of $25,000 and as of December 31, 2017, had recorded $25,000 of amortization. The note matures on November 1, 2017 and bears interest at 8%. On April 26, 2017, Eagle sold its convertible note to PureEnergy 714 LLC (“PureEnergy”) with no change in terms. As of March 31, 2018, there is $0 of accrued interest. On June 29, 2017, the Company issued 791,140 shares of common stock to PureEnergy for the conversion of $12,501. On July 19, 2017, the Company issued 748,934 shares of common stock to PureEnergy related to the conversion of $13,481. On May 23, 2017, the Company executed a convertible promissory note with PureEnergy for $15,475. The note has a conversion discount of 45% based on the lowest closing price of the 20 days prior to conversion. The Company recorded a debt discount of $8,481. The note matures on February 23, 2018 and bears interest at 8%. On October 30, 2017, the balance of the note and the accrued interest was converted into 1,006,768 shares of common stock. See Note 12. On May 10, 2017, the Company executed a convertible promissory note with Power Up for $75,000. The note has a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. The note matures on February 23, 2018 and bears interest at 8%. On September 28, 2017, Pure Energy purchased the May 10, 2017 convertible promissory note between the Company and Power Up. The Power Up convertible promissory note was for $78,427. The Company and Pure Energy entered into a revised convertible promissory note to replace the Power Up convertible promissory note as stated below. On November 9, 2017, Pure Energy converted the entire note and accrued interest into 5,764,490 shares of common stock. See Note 12. On January 26, 2018, the Company issued to Pure Energy 1,933,848 shares of common stock in consideration of its conversion of a second convertible promissory note for $33,842 (see Note 11) that the Company issued to Pure Energy on September 27, 2017 in conjunction with Pure Energy’s payoff of the May 10, 2017 Power Up convertible note. On June 20, 2017, the Company executed a convertible promissory note with Power Up for $38,000. The note has a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. The Company recorded a debt discount of $19,611 and as of the date of pay off, had recorded $6,609 of amortization. The note matures on February 23, 2018 and bears interest at 8%. On December 15, 2017, the principal and accrued interest was paid in full. On July 20, 2017, the Company executed a convertible promissory note with Power Up for $38,000. The note has a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. The Company recorded a debt discount of $14,829 and as of March 31, 2018, had recorded $7,455 of amortization. The note matures on August 11, 2018 and bears interest at 8%. As of March 31, 2018, there is $0 of accrued interest. On January 19, 2018, Pure Energy converted into 2,008,740 shares of Company common stock: (i) the principal balance of the $38,000 convertible promissory note it previously acquired from Power Up and (ii) $2,175 of accrued interest in connection with that note ($40,175 in total). That note, executed by the Company on July 20, 2017, had a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. In conjunction with its conversion of that note, on January 19, 2018, Pure Energy also received 800,918 shares of common stock – (i) $19,826.19 in conjunction with the settlement amount owed by the Company to Power Up at the time Pure Energy acquired that note from Power Up in connection with that note, and (ii) $3,000 as a transaction fee ($22,826.19 in total). On August 11, 2017, the Company executed a convertible promissory note with LG Capital (“LG”) for $42,000. The note has a conversion discount of 35% based on the lowest closing price of the 12 days prior to conversion. On February 1, 2018, the Company paid LG Capital $58,813 to retire the convertible promissory note it issued to LG Capital on August 11, 2017 for $42,000. The repayment amount included $1,565 of accrued interest and a payment premium of $15,248. On September 26, 2017, the Company executed a convertible promissory note with Power Up for $53,000. The note has a conversion discount of 35% based on the lowest closing price of the 10 days prior to conversion. On February 8, 2018, the Company paid Power Up $71,913 to retire in full this convertible note. On September 27, 2017, the Company executed a convertible promissory note with Pure Energy for $78,427 to replace the May 10, 2017 convertible note with Power Up, as reflected above. The note has a conversion discount of 35% based on the lowest closing price of the 12 days prior to conversion. On November 9, 2018, the principal and accrued interest was converted into 5,765,490 shares of common stock. (See Note 12.) In conjunction with the payoff of the May 10, 2017 Power Up convertible note, the Company incurred a prepayment penalty of $28,496, which Pure Energy paid to Power Up. The Company issued a second convertible promissory note to Pure Energy, in consideration of its payment to Power Up, for $33,842, which included the prepayment penalty and legal fees of $5,346. On January 26, 2018, the Company issued to Pure Energy 1,933,848 shares of common stock in consideration of its conversion of a second convertible promissory note for $33,842 (see Note 12). On January 17, 2018, Pure Energy acquired from Power Up the $38,000 note executed by the Company on July 20, 2017. On January 19, 2018, Pure Energy converted into 2,008,740 shares of Company common stock: (i) the principal balance of the $38,000 convertible promissory note it acquired from Power Up on January 17, 2018 and (ii) $2,175 of accrued interest in connection with that note ($40,175 in total) (see Note 12).

12. Stockholders' Equity

12. Stockholders' Equity	9 Months Ended
	Mar. 31, 2018
Equity [Abstract]
Stockholders' Equity	NOTE 12 – STOCKHOLDERS’ EQUITY Series A Preferred Stock On May 24, 2016, the Board of Directors of the Company authorized amending the Company’s Articles of Incorporation to authorize 10,000,000 shares of “blank check” preferred stock and designate 1,000,000 of the shares as Series A preferred stock. Each share of the Series A preferred stock is entitled to 500 votes and is convertible into 100 shares of common stock. Common Stock The Company was authorized to issue up to 75,000,000 shares of common stock, par value $0.001 per share. On January 21, 2015, the Company increased its authorized capital to 500,000,000 shares of common stock. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights. In the first quarter of fiscal year 2018, the Company issued 1,793,195 shares of common stock which were recorded as issuable as of June 30, 2017. On July 19, 2017, the Company issued 748,934 shares of common stock to PureEnergy related to the conversion of $13,481 of a convertible promissory note. On July 31, 2017, the Company issued 5,784,061 shares of common stock to Cliff Perry for accrued compensation of $112,500. See Note 6. On July 31, 2017, the Company issued 2,699,228 shares of common stock to Raymond Medeiros for accrued compensation of $52,500. See Note 6. On August 23, 2017, the Company issued 500,000 shares of common stock to Frank Dobrucki for services valued at $22,000. On August 14, 2017, the Company issued 500,000 shares of common stock to Nuaxon Bioscience as part of the agreement for exclusive rights to market and sell their equipment. The shares were valued at $22,000. On August 17, 2017, the Company issued 345,451 shares of common stock to Lakeport Business Services, Inc. for accounts payable $9,450. On August 25, 2017, the Company issued 600,000 shares of common stock to Christopher Thompson as a bonus in August 2017. The shares were valued at $48,900. On August 25, 2017, the Company issued 550,000 shares of common stock to Joshua Halford for services in August 2017. The shares were valued at $44,825. On August 28, 2017, the Company issued 1,061,500 shares of common stock to Christopher Sloan for services in May 2017 (661,500 shares) and for accrued expenses of $23,075 (400,000 shares of common stock). The shares were valued at $52,175. On August 28, 2017, the Company issued 500,303 shares of common stock to Neil Dutson for services valued at $37,173. On August 29, 2017, the Company issued 100,000 shares of common stock to Marc Hatch for services valued at $7,430. On October 6, 2017, the Company issued 400,000 shares of common stock to Jason Edwards for services in October 2017 valued at $16,280. On October 6, 2017, the Company issued 600,000 shares of common stock to Michael Ostrander for services in October 2017 valued at $33,870. On October 7, 2017, due to the agreement with Valencia (see Note 2), the Company owed Valencia an additional 4,142,857 shares of common stock, which were recorded as issuable. The Company recorded a contingent liability of $174,000 associated with this obligation. On January 29, 2018, because of the increase of the Company’s common stock, Valencia agreed to the accept the initially issued 3,000,000 shares of common stock as satisfaction of the obligation to pay to Valencia in connection with the Company’s May 30, 2017 Asset Purchase Agreement with Valencia to acquire certain of its assets without the need to issue additional true-up shares of the Company’s common stock. The January 29, 2018 agreement relieved the Company of the contingent liability of issuing additional shares. See Note 17. On October 23, 2017, the Company issued 1,001,250 shares of common stock to Timothy Puetz for services in October 2017 valued at $20,025. On October 23, 2017, the Company issued 1,000,000 shares of common stock to Breadfruit Tree, Inc. for inventory received in October 2017 valued at $27,200. On October 26, 2017, the Company issued 255,000 shares of common stock to Ronald Voight for services in October 2017 valued at $7,727. On October 28, 2017, the Company issued 273,333 shares of common stock to Lakeport Business Services, Inc. for services in October 2017 valued at $8,200. On October 28, 2017, the Company issued 30,000 shares to Neil Dutson for leasehold improvement performed in October 2017 valued at $900. On October 30, 2017, the Company issued 122,500 shares of common stock to legal counsel for services in October 2017 valued at $3,225. On October 31, 2017, the Company issued 850,000 shares of common stock to Paul F. Pelosi, Jr. (“Pelosi”), in regard to his appointment as Chairman of the Board on November 1, 2017, for compensation for the period November 1, 2017 through January 31, 2018. The Company is obligated to issue on February 1, 2018, an additional 1,250,000 options for common stock with an exercise price of $0.04, with an expiration date eighteen months after issuance. On February 12, 2018, the Company issued 1,250,000 warrants for common stock to Paul Pelosi in satisfaction of this obligation (see Note 13). The warrants have an exercise price of $0.04 and expire August 11, 2018. On October 25, 2017, the Company issued 250,000 shares of common stock to Frank Dobrucki for services in October 2017 valued at $7,500. On November 2, 2017, the Company issued 250,000 shares of common stock to Victor Park, a vendor, for services in October 2017 valued at $7,725. On November 3, 2017, the Company issued 1,006,768 shares of common stock to PureEnergy for the conversion of $15,475 of a convertible promissory note (see Note 11). On November 9, 2017, the Company issued 5,764,490 shares of common stock to Pure Energy for the conversion of $80,077 of principal and accrued interest of a convertible promissory note (see Note 11). On November 9, 2017, the Company sold 4,785,459 shares of common Stock to Pure Energy for $83,745.53, based on a per share price of $0.0175. On November 10, 2017, the Company sold 967,000 shares of common stock to Pelosi for $14,500, based on a per share price of $0.01499. On November 28, 2017, the Company issued 730,769 shares of common Stock to Michael Ostrander for services in October 2017 and November 2017. The shares for October 2017, which were effective October 1, 2017, were 500,000, whereas the shares for November 2017, which were effective November 1, 2017, were 230,769. The shares were valued at $40,119. On November 30, 2017, the Company recorded 600,000 shares of common stock as issuable to Alan Stone & Co. (“Stone”) in connection with various consulting services provided in 2017. The shares were valued at $36,750. On January 5, 2018 as amended on February 5, 2018, with an effective date of January 5, 2018, the Company consummated its previously-announced acquisition of 100% of the capital stock of Green Market Europe, S.L. (“GME”), a Spanish producer of hemp products. In partial consideration for the acquisition, the Company paid to GME’s seller 4,220,000 shares of the Company’s common stock valued at $295,400. On January 15, 2018, the Company issued to Stone 600,000 shares of common stock which were recorded as issuable as of December 31, 2017. On January 17, 2018, Pure Energy acquired 526,315 shares of the Company’s common stock for $25,000. On January 18, 2018, in connection with the Company’s appointment of Richard Groberg (“Groberg”) as its Chief Financial Officer to serve for an initial, two-year term, the Company (i) issued Groberg’s company, RSGroberg Consulting, LLC, 800,000 shares of common stock, and (ii) $5,000 per month compensation payable: (1) prior to the date that the Company is paying monthly compensation to its directors primarily in cash, in 600,000 shares of common stock (representing the first 12 months’ compensation), and (2) payable in cash thereafter. The common stock received was valued at $81,200 and $60,900, respectively. On January 19, 2018, Pure Energy converted into 2,008,740 shares of Company common stock: (i) the principal balance of the $38,000 convertible promissory note it acquired from Power Up on January 17, 2018 and (ii) $2,175 of accrued interest in connection with that note ($40,175 in total). The Power Up note, executed by the Company on July 20, 2017, had a conversion discount of 35% based on the lowest closing price of the 20 days prior to conversion. The common stock received was valued at $190,027 and resulted in the Company recording a loss of $157,340. On January 19, 2018, in conjunction with its conversion of that note, Pure Energy received 800,918 shares of common stock – (i) $19,826.19 in conjunction with the settlement amount owed by the Company to Power Up at the time Pure Energy acquired that note from Power Up in connection with that note, and (ii) $3,000 as a transaction fee ($22,826 in total). The common stock received was valued at $89,703 and resulted in the Company recording a loss of $66,877. On January 22, 2018, the Company issued 60,616 shares of common stock to Joseph Gurreri, an employee, in consideration of $8,550 of accrued wages. The common stock received had a value of $8,850 On January 22, 2018, Pelosi purchased 1,050,000 shares of common stock for $21,000. On January 22, 2018, the Company issued 82,192 shares of common stock to Steven Bloom in connection with consulting services provided in 2017 totaling $12,000. On January 22, 2018, the Company issued 16,952 shares of common stock to the Company’s legal counsel, in connection with services rendered totaling $2,475. On January 26, 2018, the Company issued to Pure Energy 1,933,848 shares of common stock in consideration of its conversion of a second convertible promissory note for $33,842 (see Note 11) that the Company issued to Pure Energy on September 27, 2017 in conjunction with Pure Energy’s payoff of the May 10, 2017 Power Up convertible note. The common stock received was valued at $580,154 and resulted in the Company recording a loss of $558,722. On January 22, 2018, the Company issued Reliable Steel 229,671 shares of common stock for a portion of its debt of $33,532. On January 22, 2018, the Company issued 226,497 shares of common stock to Christopher Thompson, an employee, in connection with services provided in 2017 valued at $32,842. On January 5, 2018 and February, respectively the Company issued to Michael Ostrander: (i) 150,000 shares of common stock for services performed in December 2017 valued at $12,350, and (ii) 56,930 shares of common stock for services performed in January 2018 valued at $16,737. On January 31, 2018, the Company issued to Stone 600,000 shares of common stock which were recorded as issuable as of December 31, 2017. On January 31, 2018, the Company issued 122,466 shares of common stock to Christopher Sloan, a former employee of the Company, in connection with services rendered by him to the Company in 2017 totaling $39,740. On January 31, 2018, the Company issued 47,945 shares of common Stock to Lakeport Business Services, Inc. in connection with services rendered to the Company in 2018 valued at $7,000. The stock was valued at $15,558 based on the current stock price. On January 31, 2018, Pure Energy purchased 838,126 shares of common stock for $83,813. On February 7, 2018, Neil Dutson acquired 624,000 shares of common stock for $78,000. On February 7, 2018, Weintraub Law Group, LLC (“Weintraub”) surrendered 52,779 warrants at a value of $0.3048 per share, $16,090 in total, to effect the cashless exercise of warrants to acquire 215,378 shares of common stock at $0.06 per share. The Company had issued to Weintraub 268,167 warrants to acquire common stock and 268,167 shares of common stock on October 17, 2016 for the settlement of payables of $15,065. On February 9, 2018, Douglas Montgomery, Greg Montgomery and Lesley Montgomery acquired from the Company 160,000, 80,000 and 160,000, respectively, shares of the Company’s common stock, in each case for a purchase price of $0.125 per share, for total proceeds of $50,000. On February 21, 2018, the Company issued 83,760 shares of common Stock to Lakeport Business Services, Inc. in connection with services rendered to the Company in 2018 valued at 18,000 based on the current stock price. On March 6, 2018 Vincent Moreno acquired 500,000 shares of common stock for $50,000. On March 7, 2018, Neil Dutson acquired 909,090 shares of common stock for $100,000. On March 7, 2018, Esteemed Consultants acquired 909,091 shares of common stock for $100,000. On March 14, 2018, Rex Anthony Carrol acquired 272,727 shares of common stock for $30,000. On March 15, 2018, Vision Concepts acquired 74,074 shares for $10,000. During the quarter ended March 31, 2018, the Company issued 503,535 shares of common stock to NuAxon BioScience, Inc. on behalf of Jason Edwards for services in November 2017 through March 2018 valued at $48,117. Warrants On November 2, 2015, the Company issued 1,000,000 warrants for common stock to Freedom Leaf Iberia, B.V., in regard to a contemplated future transaction between the Company and Freedom Leaf Iberia, B.V. The warrants expire on May 2, 2016. The exercise price is $0.02; and the warrant has a cashless exercise option. The warrants were valued at $0.20 per share, as defined in the section. The Company recorded an expense of $200,000. On May 2, 2016, Freedom Leaf Iberia exercised a cashless conversion of its 1,000,000 warrants for common stock of the Company into 889,868 shares of common stock of the Company. On November 2, 2015, the Company issued 1,000,000 warrants for common stock to Freedom Leaf Netherlands, B.V., in regard to a contemplated future transaction between the Company and Freedom Leaf Netherlands, B.V. The warrants expire on May 2, 2016. The exercise price is $0.02, and the warrant has a cashless exercise option. The warrants were valued at $0.20 per share, as defined in the section. The Company recorded an expense of $200,000. On May 2, 2016, Freedom Leaf Netherlands, B.V. exercised a cashless conversion of its 1,000,000 warrants for common stock of the Company into 889,868 shares of common stock of the Company. On November 2, 2015, the Company issued 500,000 warrants for common stock to a subcontractor as an incentive to their services. The warrants mature on May 2, 2016. The exercise price is $0.02, and the warrant has a cashless exercise option. The warrants were valued at $0.20 per share, as defined in the section. The Company recorded an expense of $100,000. On February 2, 2016, Dobrucki exercised a warrant for 500,000 shares of common stock for $10,000, the exercise price of the warrants at $0.02 per share. On December 14, 2015, the Company executed a convertible promissory note for $100,000 with Swiss Allied. The Company issued Swiss Allied four warrants as an incentive to the note, each for 20,000,000 shares of the Company’s common stock, for a total of 80,000,000 warrants. Each warrant has an exercise price of $0.005 per share. The four warrants, each for 20,000,000 shares of common stock, mature on March 31, 2016, June 30, 2016, October 31, 2016, and March 31, 2017, respectively. The warrants, as an incentive to the note, should have a beneficial conversion feature. As the note’s beneficial conversion feature is at the maximum, there is no beneficial conversion feature to record. If Swiss Allied exercises all warrants, the Company would receive an additional $400,000 for said shares of common stock. If Swiss Allied does not exercise all 80,000,000 warrants, by the maturation dates, as described herein, the exercise price shall be adjusted to $0.06, an increase of $0.055 per share as a penalty, which is payable to the Company at the time Swiss Allied requests to have the Rule 144 restriction removed. The interest rate for each loan tranche is 8% and is accrued with a payment date of December 15, 2016 for the first tranche and January 15, 2017 for the second tranche. The conversion price for the $100,000, which may happen any time prior to December 14, 2016, shall be the greater of $0.03 or 50% of the lowest closing price on the primary trading market on which the Company’s common stock is quoted for the five trading days immediately prior to, but not including, the conversion date, assuming that Swiss Allied has not exercised all 80,000,000 warrants for common stock. The conversion price for the $100,000, assuming that Swiss Allied has exercised all 80,000,000 warrants for common stock, shall be $0.005 per share. Swiss Allied has a right of first refusal on any future funding to the Company. Swiss Allied has the right to name a party to serve as a member of the Company’s board of directors if Swiss Allied owns at least 40,000,000 shares of the Company’s common stock. If Swiss Allied owns at least 80,000,000 shares of the Company’s common stock, they have the right to name two parties to the Company’s board of directors. The two directors will remain as long as Swiss Allied owns 55,000,000 shares of the Company’s common stock. On October 17, 2016, the Company issued 268,167 shares of common stock and 268,167 warrants for common stock to Weintraub Law Group, LLC for the settlement of payables of $15,065. On December 15, 2016, the Company and FLNL executed a license agreement (see Note 2). As part of the agreement, the Company provided FLNL with warrants to purchase up to 1,000,000 shares of common stock. The warrants have an exercise price of $0.05. The warrants can be exercised as follows: 250,000 warrants between June 2017 and August 2017; 250,000 warrants between September 2017 and November 2017; 250,000 warrants between December 2017 and February 2018, and; 250,000 warrants between March 2018 and May 2018. The warrants will be expensed according to their respective vesting schedule. On December 15, 2016, the Company and FLI executed a license agreement (see Note 2). The Company provided FLI with warrants to purchase up to 1,000,000 shares of common stock. The warrants have an exercise price of $0.05. The warrants can be exercised as follows: 250,000 warrants between June 2017 and August 2017; 250,000 warrants between September 2017 and November 2017; 250,000 warrants between December 2017 and February 2018, and; 250,000 warrants between March 2018 and May 2018. The warrants will be expensed according to their respective vesting schedule. On January 16, 2017, the Company issued 1,000,000 warrants for common stock to Vincent Moreno for future consulting services. The warrants have an exercise price of $0.05 and expire in five years. On January 30, 2017, the Company entered into an agreement with CorporateAds.com, LLC for services. The compensation provides a minimal $500 payment, 150,000 shares of common stock, and 150,000 warrants for common stock. The warrants have an exercise price of $0.10 per share with an expiration date eighteen months after issuance. The agreement is for 15 days and has an auto renewal feature for an additional 75 days. During the 75-day period, the Company will pay $500 for each additional 15 days. On February 1, 2017, both parties agreed to an addendum to the agreement to change the exercise price of $0.10 for the warrants to the following: 50,000 of the warrants have an exercise price of $0.10 per share; 50,000 of the warrants have an exercise price of $0.125 per share; and 50,000 of the warrants have an exercise price of $0.15 per share. On February 12, 2018, the Company issued 1,250,000 warrants for common stock to Paul Pelosi in lieu of a prior agreement for the Company to issue to Pelosi 1,250,000 options (see Note 12). The warrants have an exercise price of $0.04 and expire August 11, 2018. March 31, 2018 March 31, 2017 Warrants Inception Date Expected volatility 260% 231% 193% - 261% Expected dividends – – – Expected term 2 - 9 months 21 months 0.25 - 1.76 Risk-free interest rate 1.93% 1.15% 0.98% - 1.82% Stock Option Plan On June 27, 2016, the Board of Directors approved the 2016 Stock Option Plan which has reserved 10,000,000 shares of common stock. There are no stock options outstanding as of March 31, 2018.

13. Concentrations

13. Concentrations	9 Months Ended
	Mar. 31, 2018
Risks and Uncertainties [Abstract]
Concentrations	NOTE 13 – CONCENTRATIONS Concentration of Credit Risk Financial instruments, which potentially subject the Company to a concentration of credit risk, consist principally of temporary cash investments. The Company places its temporary cash investments with financial institutions insured by the FDIC. No amounts exceeded federally insured limits as of March 31, 2018. There have been no losses in these accounts through, March 31, 2018. Concentration of Revenue For the nine months ended March 31, 2018, the Company had no material customer. Concentration of Supplier The Company does not rely on any particular suppliers for its services. Concentration of Intellectual Property The Company owns or has filed for the trademarks “Freedom Leaf,” “Hemp Inspired,” “Cannabizu,” and “Cannabiz” as filed with the United States Patent and Trademark Office. The Company has filed for “Freedom Leaf” in Jamaica and Uruguay.

14. Subsequent Events

14. Subsequent Events	9 Months Ended
	Mar. 31, 2018
Subsequent Events [Abstract]
Subsequent Events	NOTE 14 – SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the financial statements were issued and filed with the Securities and Exchange Commission. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements, except as stated herein. On April 3, 2018, Esteemed Consultants, Inc. acquired from the Company 1,000,000 shares of the Company’s common stock for a purchase price of $0.075 per share, for total proceeds of $75,000. On April 16, 2018, Leafceuticals consummated the acquisition, with an effective date of April 1, 2018, of substantially all of the assets of: Earth Born, Inc., a California corporation (“Earth Born California”), Earth Born, Inc., a Delaware corporation (“Earth Born Delaware”), Irie Living, a California nonprofit mutual benefit corporation (“Irie”), and Genesis Media Works, LLC, a Utah limited liability company doing business as “Terra’s Way,” “Irie Hemp Company,” “Earth Born Botanicals,” and “Santa Cruz Hemp Company” (“Genesis” and together with Earth Born California, Earth Born Delaware, and Irie, collectively referred to herein as the “Sellers” or IRIE). Irie CBD is a California-based product line owned by the Sellers that has been operating since 2015 that formulates, manufactures and distributes CBD tinctures, CBD edibles, CBD topicals and CBD concentrates to retail markets across the country. IRIE boasts an inventory of more than 25 different products and recorded approximately $1.5 million of revenue in 2017. IRIE also leases a full manufacturing and processing facility in Oakland, California. In addition to the IRIE CBD line and associated assets and trademarks, the acquisition also includes the product lines, websites and other assets of Earth Born California, Earth Born Delaware, Irie, and Genesis. In connection with this acquisition, Leafceuticals assumed approximately $100,000 of liabilities associated with the Assets and paid the Sellers’ principals $2,200,000 (subject to adjustment), as follows: $356,080 in cash and $1,843,920 via the issuance of an aggregate of 8,118,886 shares of the Company’s common stock. The purchase price is to be reduced if: (i) the Sellers’ aggregate pre-closing revenues for the year ending December 31, 2017, were less than $1,500,000 or (ii) the Buyer’s average monthly revenues resulting from the Acquisition of the Assets for the three months following closing are less than $120,000 per month. Additionally, 1,250,000 of the Shares were to be escrowed for four months following Closing as the Buyer’s security for (i) any indemnification claims against the Sellers pursuant to the Agreement, or (ii) any pre-closing or post-closing revenue deficiency resulting in the purchase price reductions described above. On April 2, 2018, JRKH Investments, LLC purchased 54,745 shares of common stock of the Company for a purchase price of $0.091 per share, for total proceeds of $5,000. On April 2, 2018, the Company retained KSW Group, LLC as an independent contractor to serve render various services related to launching and managing various eCommerce initiatives for the Company. In connection with that appointment, the Company: (i) agreed to pay KSW monthly sales commissions based on net revenues generated by KSW, and (ii) issued to KSW 450,000 shares of the Company’s Rule 144 Common Stock. The closing price of the Company’s common stock on the issuance date of April 2, 2018 was $0.135 per share. On April 11, 2018, Kahn Family Partnership purchased 4,444,444 shares of common stock of the Company for a purchase price of $0.09 per share, for total proceeds of $400,000. On that date, the Company also issued to Kahn Family Partnership a warrant to acquire 4,444,444 shares of common stock at an exercise price of $0.13 per share. The warrant expires on April 11, 2020. On April 30, 2018, the Company appointed Nevada State Senator Richard Segerblom as a member of the Company’s Board of Directors and issued to Senator Segerblom (i) $50,000 in common stock to vest monthly for one year, with a value of $0.159 per share, for a total of 314,465 shares of common stock, and (ii) an eighteen-month warrant to acquire 500,000 shares of common stock at an exercise price of $0.10 per share. On April 30, 2018, with an effective date of April 1, 2018, the Company entered into separate consulting agreements with Karen Lane and Ricky Potts, each of whom were owners of IRIE. Pursuant to these two agreements, each agreed to continue to provide senior management services relating to the operation of IRIE under the ownership of the Company for at least nine months. In connection with these two agreements, the Company (i) granted to each 500,000 shares of common stock of the Company, vesting monthly over a period of nine months, with the vesting beginning on the effective date. The shares were valued at $61,500 for each based on the closing price of the stock on the most recent trading day prior to April 1, 2018, and (ii) agreed to a monthly compensation to each of $4,000 per month, payable using the Company’s common stock. The determination of the number of shares of stock will be calculated monthly based on the average of the OTC closing price based on the last five trading days of each month, as applicable. On May 10, 2018, the Company appointed its CFO, Richard Groberg, as a member of the Company’s Board of Directors. In consideration of his appointment, the Company agreed to issue to Mr. Groberg’s entity (1) $50,000 in common stock to vest monthly over a one-year period, at a value of $0.16 per share, for a total of 312,500 shares, and (2) an eighteen-month warrant to acquire 500,000 shares of common stock of the Company at an exercise price of $0.10 per share. On May 14, 2018, the Company sold 1,250,000 shares to each Caesar Capital Group (“Cesar”) and Joseph W and Patricia G Abrams Family Trust dtd 3/95 (“Abrams”) for $200,000 in total, based on a per share price of $0.08. In a related transaction, the Company is issuing to Caesar and Abrams 6,000,000 shares of the Company’s common stock (based on a value of $0.25 per share, or $1,500,000) in exchange for a 25% ownership interest in Cicero Transact Group, LLC (“Cicero”) On May 15, 2018, the Company issued to Cowan a License Agreement that grants him exclusive licensee distribution rights to the Freedom Leaf Inc magazine, as well as other “Freedom Leaf” branded merchandise and services. In consideration of such license, Cowan cancelled $240,000 of payables owed to him by the Company. Also, in connection with this transaction, the Company issued to Cowan a warrant exercisable between July 1, 2018 and November 15, 2019. During March through May 2018, in connection with the Company’s audit of GME, Company’s management discovered several irregularities regarding GME’s operations and its seller’s activities before and after the consummation of the Company’s acquisition of that business. Based on investigation of these discoveries, the Company, effective on June 4, 2018, consummated a termination agreement with GME’s seller. In connection with that agreement, GME’s sellers committed to return to the Company the 4,220,000 shares it previously issued. The Company will write off approximately $33,000 it had invested cumulatively in GME in addition to the stock issuance. The Company, on May 17, 2018, entered into a binding letter of intent to acquire an existing, approximately 430,000 square foot facility, that it intends to convert from a Poinsettia production facility into a light deprivation hemp production greenhouse. The total purchase price, including approximately €350,000 of rare, botanical plants that the Company acquired for €100,000 and intends to sell, is: €4,100,000 (approximately US$4.8million). The purchase consideration will be paid as follows: (i) €20,000 down, which amount already has been paid by the Company; (ii) €20,000 a month for 25 months, and (iii) €100,000 per month thereafter until paid in full. The Company intends to consummate this acquisition on or about July 2, 2018. Located in Valencia, the third largest city in Spain with an average of 300 days of sun per year and agricultural setting, the facility previously was one of the biggest Poinsettia producers in Europe. At its peak, it produced millions of Poinsettia clones and had more than 80 greenhouse workers working 24/7. The Company chose this facility due to the similarities in growing Poinsettias and Hemp and because of its light cycles and heavy machinery specific to industrial plant production. This turn-key facility includes: approximately 430,000 square feet of light deprivation greenhouse; growing supplies; polished concrete, and triple galvanized steel framework. It its fully equipped with: an automated irrigation system; a mist system; a refrigerated storage area; a light deprivation system to maximize number of crops per year; a Dutch, hydroponic set up and heating system; its own gas pipe, and five sources of irrigation water with reservoir. The facility also has office space that the Company intends to utilize to house: (i) our Spanish Media department (lamarihuana.com) and (ii) a warehouse. The purchase also includes outdoor space and the necessary structural steel sufficient to erect a new 64,000 sq. ft galvanized steel frame facility the Company intends to build to use as a GMP extraction, formulation and bottling facility. The Company intends to retain the predecessor operation’s key employees to maintain the growing facilities. Management’s goal is for this facility to become a leading greenhouse producer of cannabinoids in Europe. The Company’s goal is to grow up to two million grams of EU-certified Industrial Hemp in its first year of operations and then to expand significantly in subsequent years. The company also expects to utilize this facility to increase its Hemp research, tissue culture and extraction capabilities in the following years. On June 7, 2018, the Company retained Joseph Abrams, an individual acting as an independent contractor, to serve as a member of the Company’s Advisory Board and, in connection with that appointment, issued to Abrams: 312,500 of the Company’s Rule 144 common stock per year. The first year’s stock will be issued immediately and shall vest monthly over one year and will be valued at $0.16 per share, valuing the grant at $50,000. For the second year, the stock will be issued on June 9, 2019, and will be based on the closing price of the Company’s common stock on the OTC Markets listing on June 8, 2019. On June 21, 2018, the Company consummated the acquisition of intellectual property relating to a proprietary formula for the compounding of a nutraceutical non-liquid to inhibit the accumulation of LDL cholesterol (and an underlying patent-pending application regarding the formula) developed by Healthy Discovery Associates Corp., a Florida corporation. The patent-pending application is for a formula for a dietary supplement, which should not require a United States Food and Drug Administration (“FDA”) approval. The Company acquired the intellectual property regarding the formula and patent-pending application for 1,600,000 shares of common stock at a value of $0.25 per share, subject to a leak-out agreement and a price adjustment if the average trading price of the Company’s common stock for the five days subsequent to the six-month anniversary of the consummation of this transaction does not exceed $0.25 per share.

15. Restatement of Prior Period

15. Restatement of Prior Period Financial Statements	9 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Restatement of Prior Period Financial Statements	NOTE 15 – RESTATEMENT OF PRIOR PERIOD FINANCIAL STATEMENTS Balance Sheet and Statement of Operations The Company restated its previously issued consolidated financial statements included in the original Quarterly Report on Form 10-Q for the six months ended December 31, 2017 and the three months ended September 30, 2017 to reflect the effects of accounting and reporting errors resulting from a deficiency in its accounting and financial statement preparation process. This error and the related adjustments resulted in an understatement of net loss of $314,903 for the six months ended December 31, 2017 and the overstatement of $29,707 in derivative liabilities, the understatement of $344,610 in additional paid-in capital and the overstatement of $314,903 in accumulated deficits as of December 31, 2017. This error and the related adjustments resulted in an understatement of net loss of $143,789 for the three months ended September 30, 2017 and the overstatement of $115,975 in derivative liabilities, the understatement of $31 in common stock, the overstatement of $259,764 in additional paid-in capital and the overstatement of $143,789 in accumulated deficits as of September 30, 2017. The following tables present the impact of the financial statement error for the consolidated financials of Freedom Leaf Inc.: Balance Sheet December 31, 2017 September 30, 2017 As previously As previously reported Adjustments As restated reported Adjustments As restated Liabilities and Stockholders' Equity (Deficit) Derivative liabilities $ 47,289 $ (29,707 ) $ 17,582 $ 157,743 $ (115,975 ) $ 41,768 Common stock $ 124,591 $ 31 $ 124,622 Additional paid-in capital $ 6,110,832 $ 344,610 $ 6,455,442 $ 5,444,594 $ 259,764 $ 5,704,327 Accumulated deficit $ (6,370,985 ) $ (314,903 ) $ (6,685,888 ) $ (5,628,572 ) $ (143,789 ) $ (5,772,361 ) Statement of Operations For the Six Months Ended December 31, 2017 For the Three Months Ended September 30, 2017 Net loss attributable to common shareholders $ (1,449,997 ) $ (314,903 ) $ (1,764,900 ) $ (707,584 ) $(143,789) $(851,373) On May 10, 2018, the Company appointed its CFO, Richard Groberg, as a member of the Company’s Board of Directors. In consideration of his appointment, the Company agreed to issue to Mr. Groberg’s entity (1) $50,000 in common stock to vest monthly over a one-year period, at a value of $0.16 per share, for a total of 312,500 shares, and (2) an eighteen-month warrant to acquire 500,000 shares of common stock of the Company at an exercise price of $0.10 per share. On May 14, 2018, the Company sold 1,250,000 shares to each Caesar Capital Group (“Cesar”) and Joseph W and Patricia G Abrams Family Trust dtd 3/95 (“Abrams”) for $200,000 in total, based on a per share price of $0.08. In a related transaction, the Company is issuing to Caesar and Abrams 6,000,000 shares of the Company’s common stock (based on a value of $0.25 per share, or $1,500,000) in exchange for a 25% ownership interest in Cicero Transact Group, LLC (“Cicero”) On May 15, 2018, the Company issued to Cowan a License Agreement that grants him exclusive licensee distribution rights to the Freedom Leaf Inc magazine, as well as other “Freedom Leaf” branded merchandise and services. In consideration of such license, Cowan cancelled $240,000 of payables owed to him by the Company. Also, in connection with this transaction, the Company issued to Cowan a warrant exercisable between July 1, 2018 and November 15, 2019. During March through May 2018, in connection with the Company’s audit of GME, Company’s management discovered several irregularities regarding GME’s operations and its sellers’ activities before and after the consummation of the Company’s acquisition of that business. Based on investigation of these discoveries, the Company, effective on June 4, 2018, consummated a termination agreement with GME’s sellers. In connection with that agreement, GME’s sellers committed to return to the Company the 4,220,000 shares it previously issued to the sellers. The Company will write off approximately $33,000 it had invested cumulatively in GME in addition to the stock issuance. The Company, on May 17, 2018, entered into a binding letter of intent to acquire an existing, approximately 430,000 square foot facility, that it intends to convert from a Poinsettia production facility into a light deprivation hemp production greenhouse. The total purchase price, including approximately €350,000 of rare, botanical plants and other greenhouse supplies that the Company acquired for €100,000 and intends to sell, is: €4,100,000 (approximately US$4.8 million). The purchase consideration will be paid as follows: (i) €20,000 down, which amount already has been paid by the Company; (ii) €20,000 a month for 25 months, and (iii) €100,000 per month thereafter until paid in full. The Company intends to consummate this acquisition on or about July 2, 2018. Located in Valencia, the third largest city in Spain with an average of 300 days of sun per year and agricultural setting, the facility previously was one of the biggest Poinsettia producers in Europe. At its peak, it produced millions of Poinsettia clones and had more than 80 greenhouse workers working 24/7. The Company chose this facility due to the similarities in growing Poinsettias and Hemp and because of its light cycles and heavy machinery specific to industrial plant production. This turn-key facility includes: approximately 430,000 square feet of light deprivation greenhouse, growing supplies, polished concrete, and triple galvanized steel framework. It its fully equipped with an automated irrigation system, a mist system, a refrigerated storage area, a light deprivation system to maximize number of crops per year, a Dutch, hydroponic set up and heating system, its own gas pipe, and five sources of irrigation water with reservoir. The facility also has office space that the Company intends to utilize to house: (i) our Spanish Media department (lamarihuana.com) and (ii) a warehouse. The purchase also includes outdoor space and the necessary structural steel sufficient to erect a new 64,000 sq. ft galvanized steel frame facility the Company intends to build to use as a GMP extraction, formulation and bottling facility. The Company intends to retain the predecessor operation’s key employees to maintain the growing facilities. Management’s goal is for this facility to become a leading greenhouse producer of cannabinoids in Europe. The Company’s goal is to grow up to two million grams of EU-certified Industrial Hemp in its first year of operations and then to expand significantly in subsequent years. The Company also expects to utilize this facility to increase its Hemp research, tissue culture and extraction capabilities in the following years. On June 7, 2018, the Company retained Joseph Abrams, an individual acting as an independent contractor, to serve as a member of the Company’s Advisory Board and, in connection with that appointment, issued to Abrams: 312,500 of the Company’s common stock per year. The first year’s stock will be issued immediately and shall vest monthly over one year and will be valued at $0.16 per share, valuing the grant at $50,000. For the second year, the stock will be issued on June 9, 2019, and will be based on the closing price of the Company’s common stock on OTC Markets on June 8, 2019. On June 21, 2018, the Company consummated the acquisition of intellectual property relating a proprietary formula for the compounding of a nutraceutical non-liquid to inhibit the accumulation of LDL cholesterol (and an underlying patent-pending application regarding the formula) developed by Healthy Discovery Associates Corp., a Florida corporation. Clinical trials for the nutraceutical product based on the formula indicate significant improvements in patient cholesterol levels. The patent-pending application is for a dietary supplement, which should not require a United States Food and Drug Administration (“FDA”) approval. The Company acquired the intellectual property regarding the formula and patent-pending application for 1,600,000 shares of common stock at a value of $0.25 per share, subject to a leak-out agreement and a price adjustment if the average trading price of the Company’s common stock for the five days subsequent to the six-month anniversary of the consummation of this transaction does not exceed $0.25 per share.

1. Nature of Operations and S21

1. Nature of Operations and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Freedom Leaf Inc. (the “Company,” “we,” “us,” “our,” “Freedom Leaf” or “FRLF”) was incorporated in the State of Nevada on February 21, 2013, under the name of Arkadia International, Inc. The Company originally was engaged in the business of the acquisition of in demand equipment, cars and goods with the intent to resale these in the U.S. territory or export to overseas countries. On October 3, 2014, the Company experienced a change in control. Richard C. Cowan (“Cowan”) acquired a majority of the issued and outstanding common stock of the Company in accordance with stock purchase agreements by and between Cowan and Vladimir and Galina Shekhtman (“Sellers”). On the closing date, October 3, 2014, Cowan purchased from the Sellers 6,950,100 shares of the Company’s outstanding restricted common stock for $100,000, representing 93% of the then-outstanding common stock of the Company. On November 6, 2014, the Company merged with Freedom Leaf Inc., a private Nevada corporation. The Company changed its name from Arkadia International, Inc., to Freedom Leaf Inc. As a result of the merger, the private company was dissolved, the sole officer, director and shareholder of the private company, Clifford J. Perry, became an officer and director of the Company, and Mr. Perry received approximately 48.1% of the Company’s common stock post-merger. See Note 2 for related discussion. For financial reporting purposes, the merger was accounted for as a "reverse merger" and recapitalization rather than a business combination, and the private company was deemed to be the accounting acquirer in the transaction, with the Company deemed to be the acquired company for financial reporting purposes. Consequently, the assets and liabilities and the operations that are reflected in the historical consolidated financial statements of the Company prior to the merger are those of the private company, and were recorded at the historical cost basis of the private company, and the consolidated financial statements after completion of the merger include the assets and liabilities of both the predecessor public company and private company, the historical operations of private company, and the operations of both companies from the date of the merger. Cannabis Business Solutions Inc (“Cannabis Business Solutions”), a Nevada corporation, was formed on February 5, 2014, and is a subsidiary of the Company. This subsidiary had nominal activity until it purchased the LaMarihuana.com assets from Valencia Web Technology S.L., B-97183354, effective April 8, 2017 (see Note 2). Leafceuticals Inc (“Leafceuticals”), formerly known as Cannabiz U, Inc., a Nevada corporation, was formed on February 13, 2014, and is a wholly-owned subsidiary of the Company. This subsidiary began active operations in January 2018. Freedom Leaf International Inc. (“Freedom Leaf International”), a Nevada corporation, was formed on November 27, 2015, and is a wholly-owned subsidiary of the Company. This subsidiary has had no activity to date. Freedom Leaf Cares Inc. (“Freedom Leaf Cares”), a Nevada corporation, was formed on October 1, 2014, and is a wholly-owned subsidiary of the Company. Freedom Leaf Cares was dissolved in 2016. Until dissolution, this subsidiary had no activity.
Nature of Operations	Nature of Operations Freedom Leaf Inc., “The Marijuana Legalization Company®,” is a group of diversified, international, vertically-integrated hemp businesses and cannabis media companies. Freedom Leaf Inc. has been working since 2014 to build a diverse portfolio of related cannabis and hemp businesses through strategic acquisitions across the industry. FRLF’s portfolio of acquisitions includes our recently acquired hemp CBD product line Irie CBD; our wholly-owned hemp extraction division Leafceuticals, Inc.; our exclusive health and wellness CBD brand “Hempology;” our hemp greenhouse cultivation with recent acquisition of a facility in Valencia, Spain; our hemp-based rolling paper company Plants to Paper; two of the largest Spanish-speaking cannabis web portals in the world LaMarihuana.com Marihuana-Medicinal.com Freedom Leaf Magazine Through our targeted acquisitions and growth plan execution, the Company has built a solid foundation for our vertically-integrated cannabis/hemp company to enhance both revenue growth and shareholder value. Our cultivation and extraction divisions allow FRLF to grow and source our own hemp CBD, which allows lower production costs for our wholly-owned CBD product lines, and better gross profit, for our CBD product sales. In addition, our domestic and international media companies permit us to direct organic traffic to our eCommerce sites and retail locations. · Freedom Leaf does not handle, grow, sell, or dispense marijuana or related products in the United States. · Freedom Leaf believes that its European activities are in compliance with relevant EU laws.
Basis of Presentation	Basis of Presentation The Company prepares its consolidated financial statements in conformity with generally accepted accounting principles in the United States of America.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Freedom Leaf and its subsidiaries, Cannabis Business Solutions, Leafceuticals, Freedom Leaf Cares, and Freedom Leaf International. All significant inter-company balances and transactions have been eliminated in consolidation.
Fair Value of Measurements	Fair Value Measurements We follow accounting guidance for financial and non-financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. We currently measure and report at fair value our intangible assets (due to our impairment analysis) and derivative liabilities. The fair value of intangible assets has been determined using the present value of estimated future cash flows method. The fair value of derivative liabilities is measured using the Black-Scholes option pricing method. The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying consolidated financial statements include the amortization period for intangible assets, valuation and impairment valuation of intangible assets, depreciable lives of the web site and property and equipment, valuation of warrants and beneficial conversion feature debt discounts, valuation of derivatives, valuation of share-based payments and the valuation allowance on deferred tax assets.
Reclassifications	Reclassifications Certain amounts in the prior period consolidated financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses, total assets, or stockholders’ equity as previously reported.
Inventory	Inventory Inventory is recorded at the lower of cost or market and the cost of sales are recorded utilizing the first in first out (“FIFO”) method.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date.
Revenue Recognition	Revenue Recognition In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This update provides a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts. We have early adopted this update. We do not believe this guidance will impact the recognition of our primary source of revenue. The adoption of this guidance did not have a material impact on our consolidated financial statements.
Net Earnings (Loss) Per Share	Net Earnings (Loss) Per Share In accordance with ASC 260-10, “Earnings Per Share,” basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Dilutive common stock equivalent shares, which may dilute future earnings per share, consist of warrants to purchase 4,618,167 shares of common stock at March 31, 2018. Equivalent shares are not utilized when the effect is anti-dilutive.
Effect of Recent Accounting Pronouncements	Effect of Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (“ASU No. 2014-09”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in GAAP when it becomes effective. The new standard is effective for annual reporting periods beginning after December 15, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method, nor has it determined the effect of the standard on its ongoing financial reporting. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This update provides a comprehensive new revenue recognition model that requires a company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts. We have adopted this update. We do not believe this guidance will impact the recognition of our primary source of revenue. The adoption of this guidance did not have a material impact on our consolidated financial statements. In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements (Topic 205) Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In February 2016, the Financial Accounting Standards Board (“FASB”) issued an ASU on lease accounting. The ASU requires the lease rights and obligations arising from lease contracts, including existing and new arrangements, to be recognized as assets and liabilities on the balance sheet. The ASU is effective for reporting periods beginning after December 15, 2018 with early adoption permitted. While the Company is still evaluating the ASU, the Company expects the adoption of the ASU to have a material effect on the Company’s financial condition due to the recognition of the lease rights and obligations as assets and liabilities. The Company does not expect the ASU to have a material effect on the Company’s results of operations, and the ASU will have no effect on cash flows. The Company has evaluated all other recent accounting pronouncements and believes that none of them will have a significant effect on the Company’s financial statement.

3. Business Combination (Tables

3. Business Combination (Tables)	9 Months Ended
	Mar. 31, 2018
Business Combinations [Abstract]
Allocation of assets acquired and liabilities assumed in business combination	Consideration given: Common stock shares given $ 295,400 Total consideration given $ 295,400 Fair value of identifiable assets acquired, and liabilities assumed: Cash $ 3,546 Accounts receivable 7,430 Fixed assets, net 64,891 Intangible assets, net 5,176 Accounts payable (71,478 ) Acquisition payable (24,805 ) Payable to shareholders (5,045 ) Total identifiable net liabilities (20,285 ) Goodwill 315,685 Total consideration $ 295,400

5. Commitments and Contingenc23

5. Commitments and Contingencies (Tables)	9 Months Ended
	Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Future minimum lease payments	2018 $ 5,982 2019 18,943 Total $ 24,925

7. Other Receivables (Tables)

7. Other Receivables (Tables)	9 Months Ended
	Mar. 31, 2018
Receivables [Abstract]
Schedule of other receivables	March 31, June 30, FLNL $ 176,779 $ 173,551 FLI 246,178 240,555 BBDHS 225,186 223,711 Subtotal 648,143 637,817 Less: Allowance ( 648,143 ) – Net Balance $ – $ 637,817

8. Fixed Assets (Tables)

8. Fixed Assets (Tables)	9 Months Ended
	Mar. 31, 2018
Property, Plant and Equipment [Abstract]
Schedule of fixed assets	March 31, June 30, 2018 2017 Equipment $ 221,200 $ – Total fixed assets 221,200 – Less: Accumulated depreciation ( 24,569 ) – Fixed assets, net $ 196,631 $ –

9. Intangible Assets (Tables)

9. Intangible Assets (Tables)	9 Months Ended
	Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangible assets	March 31, June 30, 2018 2017 Website development $ 401,980 $ 12,245 Total intangible assets 401,980 12,245 Less: Accumulated amortization (85,025 ) (1,425 ) Intangible assets, net $ 316,955 $ 10,820
Amortization table	2018 $ 5,136 2019 15,127 2020 1,044 2021 1,044 2022 and thereafter 2,422 Total $ 24,773

10. Derivatives (Tables)

10. Derivatives (Tables)	9 Months Ended
	Mar. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Assumptions	March 31, 2018 June 30, 2017 Note Inception Date Volatility N/A 141% 170% - 232% Expected Term N/A 0.33 - 0.96 years 0.75 - 1.0 years Risk-Free Interest Rate N/A 0.84% 1.07% - 1.33%
Schedule of derivative instruments	Embedded conversion option derivative liability fair value on June 30, 2017 $ 52,757 Note modifications adjustment 43,866 Adjustment for extinguishment of notes and conversion of notes (91,653 ) Change in fair value in fiscal year 2018 (4,970 ) Embedded conversion option derivative liability fair value on March 31, 2018 $ –

11. Convertible Notes Payable28

11. Convertible Notes Payable, Net of Premiums and Notes Payable (Tables)	9 Months Ended
	Mar. 31, 2018
Debt Disclosure [Abstract]
Schedule of convertible notes	Convertible notes, net of discounts and notes payable March 31, 2018 June 30, 2017 Principal, Principal, Debt net of Debt net of Principal Discounts Discounts Principal Discounts Discounts PureEnergy $ – $ – $ – $ 15,475 $ (7,489 ) $ 7,986 PureEnergy – – – 13,480 (5,565 ) 7,915 PowerUp – – – 75,000 (39,330 ) 35,670 PowerUp – – – 38,000 (18,893 ) 19,107 Total $ – $ – $ – $ 141,955 $ (71,277 ) $ 70,678

12. Stockholders' Equity (Table

12. Stockholders' Equity (Tables)	9 Months Ended
	Mar. 31, 2018
Equity [Abstract]
Schedule of Assumptions	March 31, 2018 March 31, 2017 Warrants Inception Date Expected volatility 260% 231% 193% - 261% Expected dividends – – – Expected term 2 - 9 months 21 months 0.25 - 1.76 Risk-free interest rate 1.93% 1.15% 0.98% - 1.82%

15. Restatement of Prior Peri30

15. Restatement of Prior Period Financial Statements (Tables)	9 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Schedule of Error Corrections and Prior Period Adjustments	Balance Sheet December 31, 2017 September 30, 2017 As previously As previously reported Adjustments As restated reported Adjustments As restated Liabilities and Stockholders' Equity (Deficit) Derivative liabilities $ 47,289 $ (29,707 ) $ 17,582 $ 157,743 $ (115,975 ) $ 41,768 Common stock $ 124,591 $ 31 $ 124,622 Additional paid-in capital $ 6,110,832 $ 344,610 $ 6,455,442 $ 5,444,594 $ 259,764 $ 5,704,327 Accumulated deficit $ (6,370,985 ) $ (314,903 ) $ (6,685,888 ) $ (5,628,572 ) $ (143,789 ) $ (5,772,361 ) Statement of Operations For the Six Months Ended December 31, 2017 For the Three Months Ended September 30, 2017 Net loss attributable to common shareholders $ (1,449,997 ) $ (314,903 ) $ (1,764,900 ) $ (707,584 ) $(143,789) $(851,373)

1. Nature of Operations (Detail

1. Nature of Operations (Details Narrative)	9 Months Ended
	Mar. 31, 2018shares
Warrants [Member]
Antidilutive shares	4,618,167

2. Definitive Agreements (Detai

2. Definitive Agreements (Details Narrative)	9 Months Ended
	Mar. 31, 2018USD ($)
Business Combinations [Abstract]
Sales or commissions earned	$ 0

3. Business Combination (Detail

3. Business Combination (Details) - USD ($)	7 Months Ended
	Feb. 05, 2018	Mar. 31, 2018	Jun. 30, 2017
Fair value of identifiable assets acquired, and liabilities assumed:
Goodwill		$ 315,685	$ 0
Green Market Europe [Member]
Consideration given:
Common stock shares given	$ 295,400
Total consideration given	295,400
Fair value of identifiable assets acquired, and liabilities assumed:
Cash	3,546
Accounts receivable	7,430
Fixed assets, net	64,891
Intangible assets, net	5,176
Accounts payable	(71,478)
Acquisition payable	(24,805)
Payable to shareholders	(5,045)
Total identifiable net liabilities	(20,285)
Goodwill	315,685
Total consideration	$ 295,400

3. Business Combination (Deta34

3. Business Combination (Details Narrative)	Mar. 31, 2018USD ($)
Business Combinations [Abstract]
Green Market Europe Purchase Percentage Ownership	100.00%
Fair value of net assets acquired	$ 20,285

4. Going Concern (Details Narra

4. Going Concern (Details Narrative) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended
	Mar. 31, 2018	Sep. 30, 2017	Mar. 31, 2017	Dec. 31, 2017	Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2017
Going Concern
Net loss	$ (1,561,141)	$ (851,373)	$ (27,200)	$ (1,764,900)	$ (3,326,041)	$ (539,008)
Net cash used in operating activities					(520,088)	$ (222,899)
Working capital	(134,341)				(134,341)
Stockholders' equity	432,278				432,278		$ 187,818
Accumulated deficit	$ (8,247,029)	$ (5,772,361)		$ (6,685,888)	$ (8,247,029)		$ (4,920,988)

5. Commitments and Contingenc36

5. Commitments and Contingencies (Details)	Jun. 30, 2017USD ($)
Commitments and Contingencies Disclosure [Abstract]
2,018	$ 5,982
2,019	18,943
Total	$ 24,925

5. Commitments and Contingenc37

5. Commitments and Contingencies (Details Narrative) - USD ($)	9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 23,334	$ 28,021

6. Related Parties (Details Nar

6. Related Parties (Details Narrative) - USD ($)	9 Months Ended
	Mar. 31, 2018	Feb. 12, 2018	Jun. 30, 2017
Cowan
Due to related parties	$ 313,713		$ 269,226
Perry
Due to related parties	21,444		21,444
Stock issued for accrued compensation, value	$ 112,500
Stock issued for accrued compensation, shares issued	5,784,061
Medeiros [Member]
Due to related parties	$ 0		$ 0
Stock issued for accrued compensation, value	$ 52,500
Stock issued for accrued compensation, shares issued	2,699,228
Pelosi [Member]
Stock issued for compensation, shares	850,000
Stock issued for cash, shares	967,000
Proceeds from sale of stock	$ 14,500
Warrant exercise price	$ 0.04
Pelosi [Member] | Pelosi [Member]
Stock issued for cash, shares	967,000
Proceeds from sale of stock	$ 14,500
Stock date of sale	Nov. 9, 2017
Pelosi [Member] | Pelosi [Member]
Stock issued for cash, shares	1,050,000
Proceeds from sale of stock	$ 21,000
Stock date of sale	Jan. 22, 2018
Pelosi [Member] | February 12, 2018 [Member]
Warrants issued	1,250,000
Warrant exercise price		$ .04
Warrant expiration date		Aug. 11, 2018
Groberg [Member]
Stock issued for compensation, shares	1,400,000
Stock issued for compensation, value	$ 142,100

7. Other Receivables (Details)

7. Other Receivables (Details) - USD ($)	Mar. 31, 2018	Jun. 30, 2017	Mar. 31, 2017
Other receivables, gross	$ 648,143	$ 637,817
Allowance for other receivables	648,143	0
Other receivables, net	1,123	$ 637,817
FLNL [Member]
Other receivables, gross	176,779		$ 173,551
FLI [Member]
Other receivables, gross	246,178		240,555
BBDHS [Member]
Other receivables, gross	$ 225,186		$ 223,711

8. Fixed Assets (Details)

8. Fixed Assets (Details) - USD ($)	Mar. 31, 2018	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Property and equipment, gross	$ 221,200	$ 0
Less: Accumulated depreciation	24,569	0
Property and equipment, net	$ 196,631	$ 0

8. Fixed Assets (Details Narrat

8. Fixed Assets (Details Narrative) - USD ($)	9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Property and equipment, net	$ 196,631		$ 0
Depreciation expense	$ 24,569	$ 0

9. Intangible Assets (Details -

9. Intangible Assets (Details - Intangible assets) - USD ($)	Mar. 31, 2018	Jun. 30, 2017
Intangible assets, gross	$ 396,682	$ 12,245
Less: Accumulated amortization	85,025	1,425
Intangible assets, net	316,955	10,820
Website Development [Member]
Intangible assets, gross	$ 396,682	$ 12,245

9. Intangible Assets (Details-a

9. Intangible Assets (Details-amortization)	Mar. 31, 2018USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2,018	$ 5,136
2,019	15,127
2,020	1,044
2,021	1,044
2022 and thereafter	2,422
Total	$ 24,773

9. Intangible Assets (Details N

9. Intangible Assets (Details Narrative) - USD ($)	9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 83,722	$ 370

10. Derivatives (Details-assump

10. Derivatives (Details-assumptions) - Embedded Derivative Financial Instruments [Member]	9 Months Ended
	Mar. 31, 2018
Measurement Input, Option Volatility [Member] | June 2017 [Member]
Assumptions	141%
Measurement Input, Option Volatility [Member] | Note Inception Date [Member]
Assumptions	170% - 232%
Measurement Input, Expected Term [Member] | June 2017 [Member]
Assumptions	0.33 - 0.96 years
Measurement Input, Expected Term [Member] | Note Inception Date [Member]
Assumptions	0.75 - 1.0 years
Measurement Input Risk Free Interest Rate [Member] | June 2017 [Member]
Assumptions	0.84%
Measurement Input Risk Free Interest Rate [Member] | Note Inception Date [Member]
Assumptions	1.07% - 1.33%

10. Derivatives (Details - Embe

10. Derivatives (Details - Embedded conversion option) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Derivative liabilities, beginning balance			$ 52,757
Adjustment for extinguishment of notes and conversion of notes	$ 34,178	$ 5,253	(45,416)	$ (55,014)
Embedded Conversion Option [Member
Derivative liabilities, beginning balance			52,757
Note modifications adjustment			43,866
Adjustment for extinguishment of notes and conversion of notes			(91,653)
Change in fair value			(4,970)
Derivative liabilities, ending balance	$ 0		$ 0

11. Convertible Notes Payable47

11. Convertible Notes Payable, Net of Premiums and Notes Payable (Details) - USD ($)	Mar. 31, 2018	Jun. 30, 2017
Principal	$ 0	$ 141,955
Debt discounts	0	(71,277)
Convertible notes payable, net	0	70,678
Current portion	0	70,678
Non-current portion		0
Pure Energy 1 [Member]
Principal	0	15,475
Debt discounts	0	(7,489)
Convertible notes payable, net	0	7,986
Pure Energy 2 [Member]
Principal	0	13,480
Debt discounts	0	(5,565)
Convertible notes payable, net	0	7,915
Power Up 1 [Member]
Principal	0	75,000
Debt discounts	0	(39,330)
Convertible notes payable, net	0	35,670
Power Up 2 [Member]
Principal	0	38,000
Debt discounts	0	(18,893)
Convertible notes payable, net	$ 0	$ 19,107

11. Convertible Notes Payable48

11. Convertible Notes Payable, Net of Premiums and Notes Payable (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		4 Months Ended		5 Months Ended	7 Months Ended		9 Months Ended		12 Months Ended
	Jul. 19, 2017	Mar. 31, 2018	Mar. 31, 2017	Nov. 09, 2017	Oct. 30, 2017	Dec. 15, 2017	Jan. 26, 2018	Jan. 19, 2018	Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2017	Jun. 30, 2016
Beneficial conversion feature		$ 34,178	$ 5,253						$ (45,416)	$ (55,014)
Perlowin [Member] | Convertible Debt [Member]
Debt interest rate		12.00%							12.00%
Accrued interest		$ 467							$ 467
Conversion of debt, stock issued												50,000
Conversion of debt, debt converted												$ 5,000
Perlowin [Member] | Convertible Debt 2 [Member]
Debt interest rate		12.00%							12.00%
Accrued interest		$ 408							$ 408
Conversion of debt, stock issued												50,000
Conversion of debt, debt converted												$ 5,000
Ogorodnikova [Member] | Convertible Debt [Member]
Debt interest rate		12.00%							12.00%
Accrued interest		$ 986							$ 986
Conversion of debt, stock issued												125,000
Conversion of debt, debt converted												$ 12,500
Pure Energy [Member]
Conversion of debt, stock issued									7,520,192
Conversion of debt, debt converted									$ 109,033
Pure Energy [Member] | Convertible Debt [Member]
Debt interest rate					8.00%
Amortization of beneficial conversion feature					$ 8,481
Stock issued on conversion of debt, shares issued								800,918
Conversion of debt, stock issued	748,934			5,764,490	1,006,768		1,933,848	2,008,740			791,140
Conversion of debt, debt converted	$ 13,481			$ 78,427	$ 15,475		$ 33,842	$ 40,175			$ 12,501
Power Up [Member] | Convertible Debt [Member]
Debt face value		$ 75,000				$ 38,000			$ 75,000
Debt interest rate		8.00%				8.00%			8.00%
Amortization of debt discount									$ 7,455
Amortization of beneficial conversion feature						$ 6,609
Accrued interest		$ 0							$ 0
Repayment of convertible note						$ 38,000
LG Capital [Member] | Convertible Debt [Member]
Debt issuance date									Aug. 11, 2017
Debt face value		42,000							$ 42,000
Convertible rate									35.00%
Accrued interest		1,565							$ 1,565
Repayment of convertible note									58,813
Prepayment penaly and legal fees		15,248							$ 15,248
Pure Energy 3 [Member] | Convertible Debt [Member]
Debt issuance date									Sep. 26, 2017
Debt face value		53,000							$ 53,000
Repayment of convertible note									$ 71,913
Pure Energy 4 [Member] | Convertible Debt [Member]
Debt issuance date									Sep. 27, 2017
Debt face value		$ 78,427							$ 78,427
Debt interest rate		8.00%							8.00%
Conversion of debt, stock issued									5,765,490
Prepayment penaly and legal fees		$ 28,496							$ 28,496
Debt outstanding		$ 0							$ 0
Pure Energy 5 [Member] | Convertible Debt [Member]
Conversion of debt, stock issued							1,933,848
Conversion of debt, debt converted							$ 33,842
Pure Energy 6 [Member] | Convertible Debt [Member]
Conversion of debt, stock issued								2,008,740
Conversion of debt, debt converted								$ 40,175

12. Stockholders' Equity (Detai

12. Stockholders' Equity (Details Narrative) - USD ($)	6 Months Ended	9 Months Ended
	Dec. 31, 2017	Mar. 31, 2018	Jun. 30, 2017
Stock issued for acquisition, Value		$ 50,000
Pelosi [Member]
Common stock issued for warrants		1,250,000
Warrants exercise price		$ 0.04
custom:WarrantsExpireDate		Aug. 11, 2018
Stock issued for compensation, shares issued		850,000
Stock issued for compensation, value		$ 26,285
Sale of common stock, shares		967,000
Sale of common stock, value		$ 14,500
Common stock issued for option		$ 1,250,000
Stock issued for acquisition, Shares		1,050,000
Stock issued for acquisition, Value		$ 21,000
2016 Stock Option Plan [Member]
Shares reserved under plan		10,000,000
Cliff Perry [Member]
Stock issued for compensation, shares issued		5,784,061
Stock issued for compensation, value		$ 112,500
Raymond Medeiros [Member]
Stock issued for compensation, shares issued		2,699,228
Stock issued for compensation, value		$ 52,500
Frank Dobrucki [Member]
Stock issued for services, shares issued		750,000
Stock issued for services, value		$ 48,475
NuAxon BioScience, Inc [Member]
Stock issued for services, shares issued		503,535
Stock issued for services, value		$ 48,117
Nuaxon Bioscience [Member]
Stock issued for licensing rights, shares		500,000
Stock issued for licensing rights, value		$ 22,000
Lakeport Business Services [Member]
Stock issued for services, shares issued		273,333
Stock issued for services, value		$ 8,200
Stock issued for accounts payable, shares issued		345,451
Stock issued for accounts payable, value		$ 24,182
Stock issued for accounts payable, amount		$ 9,450
Christopher Thompson [Member]
Stock issued for services, shares issued		600,000
Stock issued for services, value		$ 48,900
Christopher Thompson 1 [Member]
Stock issued for services, shares issued		226,497
Stock issued for services, value		$ 33,069
Joshua Halford [Member]
Stock issued for services, shares issued		550,000
Stock issued for services, value		$ 44,825
Christopher Sloan [Member]
Stock issued for services, shares issued		661,500
Stock issued for services, value		$ 137,535
Stock issued for accounts payable, shares issued		400,000
Stock issued for accounts payable, amount		$ 23,075
Neil Dutson [Member]
Stock issued for services, shares issued		500,303
Stock issued for services, value		$ 37,203
Stock issued for leasehold improvement, shares issued		30,000
Stock issued for leasehold improvement, value		$ 900
Stock issued for acquisition, Shares		909,090
Stock issued for acquisition, Value		$ 100,000
Neil Dutson 1 [Member]
Stock issued for acquisition, Shares		624,000
Stock issued for acquisition, Value		$ 78,000
Marc Hatch [Member]
Stock issued for services, shares issued		100,000
Stock issued for services, value		$ 7,430
Jason Edwards [Member]
Stock issued for services, shares issued		400,000
Stock issued for services, value		$ 16,280
Michael Ostrander [Member]
Stock issued for services, shares issued		600,000
Stock issued for services, value		$ 24,420
Valencia [Member]
Common stock issuable		4,142,857
Contingent liability		$ 174,000
Timothy Puetz [Member]
Stock issued for services, shares issued		1,001,250
Stock issued for services, value		$ 30,038
Breadfruit Tree Inc [Member]
Stock issued for inventory received, shares issued		1,000,000
Stock issued for inventory received value		$ 27,200
Ronald Voight [Member]
Stock issued for services, shares issued		255,000
Stock issued for services, value		$ 7,650
Legal counsel [Member]
Stock issued for services, shares issued		122,500
Stock issued for services, value		$ 8,575
Victor Park [Member]
Stock issued for services, shares issued		250,000
Stock issued for services, value		$ 6,800
Pure Energy [Member]
Debt converted, shares issued		7,520,192
Debt converted, debt amount		$ 109,033
Sale of common stock, shares		4,785,459
Sale of common stock, value		$ 83,746
Stock issued for acquisition, Shares		526,315
Stock issued for acquisition, Value		$ 25,000
Stock isued for convertible promissory note, Shares		1,933,848
Stock isued for convertible promissory note, Value		$ 33,842
Common stock received		580,154
Loss on issue of convertible note		$ (558,722)
Pure Energy 1 [Member]
Stock issued for acquisition, Shares		838,126
Stock issued for acquisition, Value		$ 83,813
Stock isued for convertible promissory note, Shares		800,918
Stock isued for convertible promissory note, Value		$ 22,826
Common stock received		89,703
Loss on issue of convertible note		$ (66,877)
Pure Energy 2 [Member]
Stock isued for convertible promissory note, Shares		2,008,740
Stock isued for convertible promissory note, Value		$ 40,175
Common stock received		190,027
Loss on issue of convertible note		$ (157,340)
Stone [Member]
Common stock issuable		600,000
Stock issued for services, shares issued	600,000	600,000
Stock issued for services, value		$ 36,750
GME’s seller [Member]
Stock issued for acquisition, Shares		4,220,000
Stock issued for acquisition, Value		$ 295,400
Stone 1 [Member]
Stock issued for services, shares issued	600,000
Groberg [Member]
Stockholders' Equity Description		On January 18, 2018, in connection with the Company’s appointment of Richard Groberg (“Groberg”) as its Chief Financial Officer to serve for an initial, two-year term, the Company (i) issued Groberg’s company, RSGroberg Consulting, LLC, 800,000 shares of common stock, and (ii) $5,000 per month compensation payable: (1) prior to the date that the Company is paying monthly compensation to its directors primarily in cash, in 600,000 shares of common stock (representing the first 12 months’ compensation), and (2) payable in cash thereafter. The common stock received was valued at $81,200 and $60,900, respectively.
Vision Concepts [Member]
Stock issued for acquisition, Shares		74,074
Stock issued for acquisition, Value		$ 10,000
Rex Anthony Carrol [Member]
Stock issued for acquisition, Shares		272,727
Stock issued for acquisition, Value		$ 30,000
Esteemed Consultants [Member]
Stock issued for acquisition, Shares		909,091
Stock issued for acquisition, Value		$ 100,000
Moreno [Member]
Stock issued for acquisition, Shares		500,000
Stock issued for acquisition, Value		$ 50,000
Lakeport Business Service [Member]
Stock issued for services, shares issued		83,760
Stock issued for services, value		$ 18,000
Douglas Montgomery [Member]
Stock issued for acquisition, Shares		160,000
Greg Montgomery [Member]
Stock issued for acquisition, Shares		80,000
Lesley Montgomery [Member]
Stock issued for acquisition, Shares		160,000
Weintraub [Member]
Common stock issued for warrants		268,167
Number of warrants surrendered		52,779
Proceeds from warrants surrendered		$ 16,090
Acquisition of cashless exercise of warrants, Shares		215,378
Stock issued for settlement of payables, value		$ 15,065
Lakeport Business Services 1 [Member]
Stock issued for services, shares issued		47,945
Stock issued for services, value		$ 15,558
Christopher Sloan [Member]
Stock issued for services, shares issued		122,466
Stock issued for services, value		$ 39,740
Michael Ostrander 1 [Member]
Stock issued for services, shares issued		150,000
Stock issued for services, value		$ 12,350
Michael Ostrander 2 [Member]
Stock issued for services, shares issued		56,930
Stock issued for services, value		$ 16,737
Reliable Steel [Member]
Debt converted, shares issued		229,671
Debt converted, debt amount		$ 33,532
Legal counsel 1 [Member]
Stock issued for services, shares issued		16,952
Stock issued for services, value		$ 2,475
Steven Bloom [Member]
Stock issued for services, shares issued		82,192
Stock issued for services, value		$ 12,000
Joseph Gurreri [Member]
Common stock issued in consideration of accrued wages, Shares		60,616
Common stock issued in consideration of accrued wages, value		$ 8,550
The Company [Member]
Common stock issuable			1,793,195

15. Restatement of Prior Peri50

15. Restatement of Prior Period Financial Statements (Details - Balance Sheet) - USD ($)	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017
Derivative liabilities	$ 0	$ 17,582	$ 41,768	$ 52,757
Common stock	161,741		124,622	111,102
Additional paid-in capital	8,516,596	6,455,442	5,704,327	4,996,756
Accumulated deficit	$ (8,247,029)	(6,685,888)	(5,772,361)	$ (4,920,988)
Scenario, Previously Reported [Member]
Derivative liabilities		47,289	157,743
Common stock			124,591
Additional paid-in capital		6,110,832	5,444,594
Accumulated deficit		(6,370,985)	(5,628,572)
Adjustment [Member]
Derivative liabilities		(29,707)	(115,975)
Common stock			31
Additional paid-in capital		344,610	259,764
Accumulated deficit		$ (314,903)	$ (143,789)

15. Restatement of Prior Peri51

15. Restatement of Prior Period Financial Statements (Details - Statement of Operations) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended
	Mar. 31, 2018	Sep. 30, 2017	Mar. 31, 2017	Dec. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Net loss attributable to common stockholders	$ (1,561,141)	$ (851,373)	$ (27,200)	$ (1,764,900)	$ (3,326,041)	$ (539,008)
Scenario, Previously Reported [Member]
Net loss attributable to common stockholders		(707,584)		(1,449,997)
Adjustment [Member]
Net loss attributable to common stockholders		$ (143,789)		$ (314,903)